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Abstract
Vincent, Jacob Adam. Ph.D., Biomedical Sciences Ph.D. Program, Wright State
University, 2017. Sensorimotor Deficits Following Oxaliplatin Chemotherapy.

Neurotoxicity is one of the most significant side effects diminishing clinical
efficacy and patient quality of life during and following chemotherapy. Oxaliplatin (OX)
is a platinum based chemotherapy agent used in the treatment of colorectal cancer.
Colorectal cancer currently ranks as the 4th most common cancer, and the majority of
patients receive OX as a part of their adjuvant therapy. OX based adjuvant therapies
significantly improve 5 year survival rates, however in many cases patients must stop
treatment early because of the neurotoxic side effects. OX causes two clinically distinct
forms of neurotoxicity. Acutely, within hours and for days following OX infusion patients
experience positive symptoms including, paresthesia, cold induced pain, and muscle
cramping/fasciculation. These symptoms typically subside in between treatments but
often worsen with each successive OX infusion. Chronically, with accumulating doses of
OX and following treatment cessation, patients experience negative symptoms including
numbness, pain, and sensory ataxia. The symptoms persist in a substantial number of
patients for years following cessation of chemotherapy and significantly diminish quality
of life. While OX neurotoxicity has been widely studied, there are still fundamental gaps
in knowledge regarding (a) the mechanisms underlying acute and chronic neurotoxicity,
(b) the suggested causal link between acute and chronic OX, and (c) targeted treatment
aimed at alleviating the neurotoxic side effects of acute and chronic OX. In order to
address these gaps we applied behavioral and in vivo electrophysiological techniques
and pharmacological manipulation in chronic OX-treated, acutely OX-treated, and
control rats. Building on our recent discovery that following chronic OX-treatment
iii

muscle proprioceptors cannot sustain repetitive firing necessary for normal encoding, we
hypothesized that loss of proprioceptive signaling should result in behavioral deficits and
that impaired encoding results from disruption of persistent inward Na+ currents (NaPIC).
Using the methods above we confirmed these hypotheses and have developed a
targeted treatment that restores proprioceptive encoding after chronic OX-treatment.
Lastly, given the suggested link between acute and chronic neurotoxicity we sought to
determine the location of changes in muscle proprioceptor excitability following acute
OX-treatment.
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Chapter 1: Purpose & Aims

Purpose
Oxaliplatin induced neurotoxicity is a significant clinical problem that limits its
clinical efficacy and negatively impacts patient lives. Study of acute neurotoxicity has
failed to provide any meaningful treatment of acute symptoms and has failed to prevent
development of chronic neurotoxicity. Similarly, chronic studies have focused solely on
neuropathy and have failed to account for symptoms in patients without neuropathy.
Studies undertaken in this dissertation seek to fill the gaps in the understanding of acute
and chronic neurotoxicity. Changes in muscle proprioceptor function will be analyzed
following acute and chronic OX and changes in motor function will be analyzed following
acute OX. The purpose of these studies is to gain insight into changes that cause acute
symptoms and chronic symptoms in the absence of neuropathy with the hope of
identifying changes for targeted treatment.

Specific Aims
In order to address the specific aims in this dissertation, electrophysiological
techniques will be applied in vivo. Studies are designed to characterize deficits in
muscle proprioceptor encoding, how those changes correlate with behavior, and to
identify the mechanism(s) responsible for those changes. Further studies will be
undertaken to test the ability of different agents to improve muscle proprioceptor function
following chronic OX. Lastly, muscle proprioceptor and motor function will be studied
1

following acute OX in order to identify and localize clinically relevant changes in
excitability that result in patient symptoms.

Specific Aim 1: To test the hypothesis that OX treatment causes proprioceptive
deficits by reducing ionic currents that support sustained repetitive firing
necessary for sensory encoding
Published: A novel path to chronic proprioceptive disability with oxaliplatin: Distortion of
sensory encoding. Neurobiology of Disease. 2016 November; 95.
Complex impairment of Ia muscle spindle afferents following traumatic of
neurotoxic injury. Journal of Anatomy. 2015 August; 227
Rationale
The recent observation that OX can produce sensory symptoms, including loss of
cutaneous sensation, proprioceptive deficits, and pain in patients that have no evidence
of neuropathy suggests that additional mechanisms are at play (Burakgazi et al., 2011).
Support for this novel idea is found in that following chronic OX treatment muscle
proprioceptors are unable to maintain repetitive firing necessary for sensory encoding.
Specifically, Ia muscle spindle afferents fail to encode static muscle length, while effects
on rapid stimuli are unaffected (Bullinger et al., 2011b). Other muscle proprioceptors,
group II and Ib golgi tendon organ afferents were also affected but to a lesser extent.
Importantly, the animals used in these studies showed no evidence of neuropathy
(Bullinger et al., 2011b). Thus, disruption of sensory encoding by OX is a novel idea
potentially explaining sensory symptoms in the absence of neuropathy.
The inability to sustain repetitive firing suggests that OX is disrupting an ionic
current that supports repetitive firing during a sustained stimulus. In dorsal root ganglion
neurons and other neuronal subtypes, persistent inward currents (PIC) underlie
repetitive firing during sustained stimuli (Lee and Heckman, 2001; Harvey et al., 2006a;
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Xie et al., 2011). In these various neuronal subtypes sodium persistent inward current
(NaPIC) is essential for generating and maintaining repetitive firing. If OX is disrupting a
NaPIC necessary for normal sensory encoding, then drugs given acutely that block
NaPIC should reproduce the OX firing phenotype.

Specific Aim 2: To test the hypothesis that drugs that increase persistent inward
currents can restore sensory encoding following OX treatment.

Rationale
Persistent inward currents have been identified in numerous neuronal subtypes
including, motoneurons, dorsal root ganglion neurons, and cortical neurons (Crill, 1996;
Lee and Heckman, 2001; Harvey et al., 2006a). Their role is best defined in the alpha
motoneuron where they have been shown to be essential for the generation and
maintenance of repetitive firing (Lee and Heckman, 1998, 2001; Theiss et al., 2007).
Preliminary evidence (Vincent et al., 2015) and results from aim 1 support the notion that
chronic OX treatment disrupts a NaPIC resulting in encoding deficits in muscle
proprioceptors. The failure of muscle proprioceptors to maintain repetitive firing during
static and slowly changing muscle length represent a critical loss of signal to the central
nervous system. These findings are the first suggestion outside of neuropathy to explain
symptoms following OX. Therefore, NaPIC is a potential therapeutic target following OX.
If NaPIC can be increased after OX, then there is potential to restore the muscle length
and force signals arising from muscle proprioceptors.

Specific Aim 3: To determine if spontaneous activity following acute OX in muscle
proprioceptors arises from sensory nerve terminals
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Rationale
Within hours and for days following infusions of OX, greater than 90 % of patients
describe abnormal sensations, pain, muscle spasm, and muscle fasciculation (Argyriou
et al., 2008; Argyriou et al., 2014). These symptoms typically last less than one week,
but re-occur following every OX infusion (Krishnan et al., 2005; Park et al., 2009b; Park
et al., 2011b; Park et al., 2013). The common mechanism attributed to this acute
syndrome is sensory and motor axonal hyper-excitability (Krishnan et al., 2006; Park et
al., 2009b; Park et al., 2011b). Support for this comes from several different studies
showing OX alters the function of nodal voltage-gated Na+ channels either in vitro, or by
clinically used techniques such as threshold tracking (Adelsberger et al., 2000; Grolleau
et al., 2001; Benoit et al., 2006; Krishnan et al., 2006; Park et al., 2011b).
The importance of understanding OX acute effects is demonstrated by the
correlation between the severity of acute symptoms and the likelihood of developing
chronic neurotoxicity (Krishnan et al., 2005, 2006; Park et al., 2009a). Information
gained from previous studies has been used to identify neuroprotective strategies
targeted at blocking the acute syndrome in order to prevent the chronic neurotoxicity.
Unfortunately, these strategies have failed and there is no current effective treatment for
blocking the acute syndrome and providing neuroprotection against chronic
neurotoxicity. Preliminary findings (Vincent et al., 2015) and results from aim 1
demonstrate that changes following chronic OX occur at the sensory nerve terminal. If
acute and chronic neurotoxicity are linked then acute OX may also target the sensory
nerve terminal.
In order to nail down the origin of hyperexcitability we will use in vivo intra-axonal
recording, the gold standard for assessing axon parameters and novel spike triggered
4

averaging to localize spike origin. These in vivo techniques will allow us to study the
intact proprioceptor system in a way that has not previously been done.
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Chapter II: Significance/Background
Chemotherapy induced neurotoxicity is a poorly understood dose limiting side effect of
chemo agents limiting the efficacy of cancer treatment:

Oxaliplatin (OX), a 3rd generation platinum chemotherapy drug, is one of the most
commonly used adjuvant chemotherapeutic agents in the treatment of colorectal cancer.
Colorectal cancer ranks as the 4th most common cancer, with nearly 140,000 new cases
occurring each year (cancer.gov). Currently there are nearly 1.2 million people living
with colorectal cancer (cancer.gov), the majority of these patients receive OX as part of
their adjuvant treatment. The efficacy of OX treatment is limited by its neurotoxicity
(Argyriou et al., 2014; Sereno et al., 2014), which forces many patients to stop treatment
early (Argyriou et al., 2014). OX neurotoxicity can be divided into two different phases.
Up to 95% of patients experience acute neurological symptoms including paresthesia,
muscle spasms, and cold hypersensitivity (Argyriou et al., 2008; Argyriou et al., 2013a).
Acute hyper-excitability following treatment is related to changes in ions channels.
Acute OX in vivo administration alters voltage-gated Na+ current in sensory and motor
axons (Krishnan et al., 2006; Park et al., 2009b; Park et al., 2011b). OX causes
hyperpolarized shifts in the voltage dependent activation of voltage-gated Na+ channels
(Adelsberger et al., 2000; Benoit et al., 2006). These changes in voltage-gated Na+
current are thought to arise via Ca2+ chelation by oxalate, a metabolite of OX (Grolleau
et al., 2001; Benoit et al., 2006; Argyriou et al., 2008; Argyriou et al., 2014).
Additionally, OX has been shown to increase TRPA currents in sensory neurons
contributing to the cold hypersensitivity (Zhao et al., 2012; Nativi et al., 2013).
6

Patients who continue OX treatment experience chronic neurological symptoms
that are primarily sensory, including decreased cutaneous sensation, pain,
proprioceptive deficits, and sensory ataxia (Bennett et al., 2012; Beijers et al., 2014).
Clinically, these symptoms are commonly referred to as chemotherapy induced
peripheral neuropathy (CIPN) and their severity is correlated with cumulative dose of
OX. In a self-report questionnaire patients reported feeling unsteady and clumsy, nearly
falling over, difficulty walking and driving, and decreased sensation in their toes and
fingers (Bennett et al., 2012). Similar to other chemotherapy induced neuropathies, OX
induced neuropathy is length dependent with the longest axons being effected first
(Cavaletti, 2014). The severity of neuropathy (peripheral axon loss) is scored using a
combination of electrophysiology (reduced sensory nerve action potential amplitudes),
epidermal punch biopsy (intra-epidermal nerve fiber density), and clinical assessment
(sensory and reflex testing) (Burakgazi et al., 2011; Park et al., 2011a; Park et al.,
2012b). These dose limiting neurotoxic effects are evident in up to 90% of OX patients,
with over 50% of those cases being either moderate (grade 2) or severe (grade 3) (Park
et al., 2011a). Neurological deficits can persistent for up to 2 years after treatment in up
to 1/3 of patients (Park et al., 2011a). The common accepted pathogenic mechanism of
OX’s chronic effects results from its accumulation in the dorsal root ganglion where it
causes decreases in cellular metabolism, oxidative stress, and axonal transport
(Argyriou et al., 2008; Park et al., 2013; Argyriou et al., 2014; Briani et al., 2014;
Cavaletti, 2014; Avan et al., 2015; Carozzi et al., 2015). Within the dorsal root ganglion
OX causes atrophy in large diameter neurons marked by parvalbumin (Jamieson et al.,
2005), and morphometric changes indicative of cell damage (Cavaletti et al., 2001).
Changes in the dorsal root ganglion are associated with loss of axons in the periphery
(Cavaletti et al., 2001).
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OX Chronic Neurotoxicity: Additional Mechanisms
Within the clinical literature there is disparity between the clinical signs of
neuropathy and patient reported symptoms. Patients frequently report symptoms that
are more severe than suggested by clinical measurements of neuropathy (Park et al.,
2013). This disparity is supported by a recent clinical study that found subsets of
patients that describe the same sensory symptoms in the absence of any clinical signs
of peripheral neuropathy, i.e. reduced sensory nerve action potential amplitude (SNAP),
or intraepidermal nerve fiber density (IENFD) (Burakgazi et al., 2011). If patients
experience sensory symptoms in the absence of neuropathy then there must be
additional mechanisms contributing to sensory deficits.
Sensory symptoms experienced by patients could potentially be caused by either
problems in the periphery, i.e. encoding or by changes that limit the transmission of
sensory information to the central nervous system (CNS). The focus of this dissertation
is to investigate peripheral mechanisms other than neuropathy that could cause sensory
deficits following OX treatment.

Novel Peripheral Mechanism: OX Impairs Muscle Proprioceptor Encoding:
Recent evidence demonstrates that following OX treatment muscle proprioceptor
sensory encoding is impaired (Bullinger et al., 2011b). Muscle proprioceptors (muscle
spindle and golgi tendon organs) lie within the muscle and supply the CNS with critical
length and force feedback (Matthews, 1972). More specifically, Ia muscle spindle
afferents are activated by the stretch of their parent muscle. These mechanical signals
are encoded into action potentials out in the periphery and are conducted centrally
where Ia muscle spindle afferents synapse with a wide variety of CNS neurons. Most
notably Ia muscle spindle afferents form a monosynaptic connection with alpha
motoneurons (Matthews, 1972). This connection forms the basis for the stretch reflex,
8

where stretching a muscle activates Ia muscle spindle afferents, which through their
monosynaptic connection excite motoneurons, causing them to fire action potentials
resulting in muscle contraction (Proske and Gandevia, 2009). This sensory feedback is
essential for the sensorimotor control of locomotion (Proske and Gandevia, 2012).
In response to ramp-hold-release stretch (3 mm, 20 mm/s) normal rodent Ia
muscle spindle afferents display a high frequency initial burst at the onset of stretch,
followed by a rapid increase in firing until the peak of the ramp, and then a sustained
discharge during the hold phase (Fig. 1 A). Normal Ia muscle spindle afferents are
slowly adapting (Fig. 1A), firing >800 ms through the 1000 ms hold phase of muscle
stretch (Bullinger et al., 2011a; Vincent et al., 2015). Following a 4-week OX (40 mg/kg
cumulative dose) treatment regime and a 3-5 week coasting period, 50% of sampled Ia
muscle spindle afferents fired ≤ 500 ms during the hold phase (Bullinger et al., 2011a;
Vincent et al., 2015) (Fig. 1B). The loss of hold phase firing was not due to an inability to
conduct action potentials centrally, as shown in Fig. 1C Ia muscle spindle afferents were
capable of conducting superimposed vibration with high fidelity. The inability of Ia
muscle spindle afferents to encode sustained muscle stretch results in the loss of critical
length signal to the CNS. This encoding deficit occurred in the absence of any
neuropathy (Fig. 1 D, E) making it distinct from any previously described form of
chemotherapy neurotoxicity.

Muscle Proprioceptors: Muscle Spindles
Muscle spindles lie within the surrounding muscle, and are made up of intrafusal
fibers surrounded by a capsule (Matthews, 1972; Hunt, 1974). The intrafusal fibers
within spindles orient themselves in parallel with the surround extrafusal tissue. Their
specific orientation with respect to the extrafusal muscle allows them to detect muscle
stretch amplitude and velocity (Matthews, 1972; Hunt, 1974).
9

The spindle structure can be divided in to two segments. Within the polar regions
of the spindle central nuclei are sparsely spaced. Near the center of the spindle is the
equatorial region, which contains densely packed nuclei (Banks et al., 1982). The
intrafusal fibers within the equatorial region can be further divided into larger type 1 and
type 2 nuclear bag fibers, and smaller nuclear chain fibers. Intrafusal fibers receive both
sensory and motor innervation (Boyd, 1968; Boyd and Ward, 1975; Boyd et al., 1977).
The first type of sensory innervation is the annulosprial endings of Ia muscle
spindle afferents. These endings form coils around the intrafusal fibers. The second
type of ending is referred to as a flower spray ending of group II muscle spindle
afferents, and is most often found in the juxta-equatorial position (Barker, 1948; Hunt,
1974; Banks et al., 1982; Banks et al., 2009). Typically, each spindle receives
innervation from a single Ia muscle spindle afferent and multiple group II muscle spindle
afferents (Banks et al., 1982).
Proprioceptive afferents that innervate muscle spindles encode changes in
muscle length, and velocity (Matthews, 1972). As a group, given their in parallel
orientation with the extrafusal fibers, muscle spindle afferents fail to firing during muscle
shortening, such as during active muscle contraction (Matthews, 1972). The
responsiveness of these different muscle spindle afferent types to different stimuli allows
for their distinction. Ia muscle spindle afferents show a much higher dynamic stretch
sensitivity, initial bursting at the onset of muscle stretch, and cessation of firing on
release, and are uniquely sensitive to high frequency vibrations of 100-150 Hz
(Matthews, 1972; De-Doncker et al., 2003; Haftel et al., 2004; Bullinger et al., 2011a).
These properties allow Ia muscle spindle afferents to encode both muscle length and
velocity changes. In contrast, Group II muscle spindle afferents are much less sensitive
to dynamic stretch, lack initial bursting, are relatively insensitive to muscle vibration, and
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continue to fire upon release from stretch. Group II muscle spindle afferents function as
length sensors (Matthews, 1972; De-Doncker et al., 2003).
Muscle spindles are innervated by small motor axons arising from gamma
motoneurons. Gamma motoneurons are interspersed within their associated muscle
motor pools within lamina IX of the ventral horn (Burke et al., 1977). In comparison with
alpha motoneurons, gamma motoneurons are much smaller, show less dendritic
branching, and lack monosynaptic connection with 1a afferents and recurrent collaterals
(Eccles et al., 1960; Burke et al., 1977; Lagerback, 1985). Gamma motoneurons are
modulated by supraspinal structures, however this input and therefore gamma
motoneuron output is greatly decreased during anesthesia (Haftel et al., 2004).
Gamma motoneurons can be subdivided into dynamic and static groups. The
dynamic gamma axons innervate the type 1 nuclear bag fibers (dynamic Bag1 fiber),
while the static gamma axons innervate the type 2 nuclear fibers (static bag2 fiber), and
the nuclear chain fibers. Each type 1 nuclear bag fiber is innervated by one or two
dynamic gamma motor axons, while each type 2 nuclear bag and chain fibers are
innervated by three to seven static gamma motor axons (Matthews, 1962; Matthews,
1972; Boyd et al., 1977; Banks et al., 1982). Gamma motoneurons extrinsically
modulate muscle spindle output by contracting intrafusal muscle fibers (Boyd and Ward,
1975). Their segregated innervation results in differential modulation of dynamic and
static responsiveness. Dynamic gamma motoneurons cause an increase in the
dynamic responsiveness, while static gamma motoneurons increase the static
responsiveness of the muscle spindle afferent (Hunt, 1974; Boyd and Ward, 1975;
Banks et al., 1997). This is accomplished by contraction of intrafusal muscle fibers, and
compressing the sensory nerve terminal. At the onset of muscle lengthening, the
shortened and taunt intrafusal muscle fibers stretch along with the sensory nerve
terminal to a greater degree, allowing more current to flow into the sensory axon (Hunt,
11

1974; Boyd and Ward, 1975; Banks et al., 1997). This results in an increase in firing
during dynamic or static stretch depending on which intrafusal fibers were stimulated, i.e.
Bag1, or Bad2/chain.

Muscle Proprioceptors: Golgi Tendon Organ
In contrast to muscle spindles, golgi tendon organs consist of bundles of collagen
oriented in series with the extrafusal muscle fibers (Hunt, 1974; Zelena and Soukup,
1983; Jami, 1992). Each golgi tendon organ receives innervation from a single group Ib
golgi tendon organ afferent. Given their in series orientation, Ib golgi tendon organ
afferents increase their firing during active muscle contraction, distinguishing them from
muscle spindle afferents (Houk et al., 1971; Matthews, 1972; Zelena and Soukup, 1983;
Jami, 1992). In fact, contraction of the motor unit in which a Ib golgi tendon organ
afferent lies is considered their adequate stimulus. Thus, Ib golgi tendon organ afferents
are considered force sensors (Houk et al., 1971; Jami, 1992). Their responsiveness to
passive muscle stretch is thought to lie outside the physiological range of passive
muscle stretch (Houk et al., 1971; Jami, 1992). Other studies though have suggested
that Ib golgi tendon organ afferents do in fact respond to passive muscle stretch within
the physiological range (Stephens et al., 1975).
Together Ib golgi tendon organ afferents and muscle spindle afferents project
into the spinal cord where they ascend through the dorsal spinocerebellar tract and
dorsal column medial lemniscal system to supraspinal centers, and synapse with
multiple targets within the spinal cord; including interneurons, and motoneurons.
Together the circuits that these afferents feed into provide essential feedback about limb
position, allowing for control of locomotion (Proske and Gandevia, 2012).

12

Mechano-transduction and Encoding
The arrival of action potentials within the central nervous system relies on three
processes in peripheral signaling: mechanotransduction, encoding of action potentials,
and orthodromic conduction. Mechano-transduction and encoding has been best
described in Ia muscle spindle afferents. Fig. 2 provides a diagrammatic representation
of these processes. Signaling begins with the stretch activation of mechanically gated
ion channels allowing sodium (and to a lesser extent calcium) ions to enter the afferent
terminal producing a depolarizing receptor potential (Hunt, 1974; Hunt et al., 1978;
Bewick and Banks, 2015). The size and shape of the receptor potential reflect the
different dynamic and static components of mechanical perturbation. Recent evidence
indicates that DEG/ENaC, and Peizo 2 channels may be responsible for the receptor
potential (Hunt, 1974; Hunt et al., 1978; Bewick and Banks, 2015; Woo et al., 2015).
After formation, the receptor potential spreads the unmyelinated heminode of the
afferent where its features are encoded in firing patterns of action potentials by voltagegated Na+ and K+ channels. The final step in signaling proceeds as action potentials
propagate from the heminodes orthodromically along the afferent axon as it traverses
the peripheral nerve and enters the central nervous system.
The output of Ia muscle spindles can be modulated intrinsically by Ca2+ activated
mechanisms (Bewick and Banks, 2015) and extrinsically by gamma motoneuron
innervation of intrafusal muscle fibers (Taylor et al., 2006). Muscle spindle afferent firing
is reduced by negative feedback initiated within the heminode by action potentials that
open P/Q-type Ca2+ channels. This Ca2+ current suppresses afferent firing by activating
large (BK) and small conductance (SK) K+ channels (Bewick and Banks, 2015). This
negative feedback mechanism suppresses afferent firing on a time scale of fractions of a
second. Additionally there is a distinct intrinsic mechanism that increases or maintains
13

spindle firing. In this autogenic excitatory mechanism, increase Ca2+ causes glutamate
release from synaptic like vesicles in the afferent terminal, which bind auto-genically to a
PLD linked metabotropic glutamate. This activates an unknown second messenger
cascade that serves to increase afferent firing over a time course of minutes to hours
(Bewick et al., 2005; Bewick and Banks, 2015).

14
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Fig. 1. Chronic OX disrupts muscle proprioceptor encoding(Bullinger et al., 2011b;
Vincent et al., 2015). (A) Control slowly adapting Ia muscle spindle afferent firing
response (gray lines are action potentials, black dots representation instantaneous firing
rates) to ramp-hold-release stretch (bottom trace in B). (B) Following OX Ia muscle
spindle afferents were unable to maintain hold phase repetitive firing, while encoding
during the ramp phase was normal. (C) Superimposed 100 Hz vibration (bottom trace)
restored firing during the hold phase. (D) Animals displayed no reduction in SNAP
amplitude or changes in conduction delay. (E) Following OX treatment Ia muscle spindle
afferents maintained normal innervation of muscle spindles. Staining the soleus muscle
with PGP 9.5 demonstrates normal innervation and counts of muscle spindles as
compared to controls. Note the intact annulospiral ending of a Ia muscle spindle
afferent.
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Fig. 2. Mechanosensory model of Ia muscle spindle afferent encoding adapted
from Bewick and Banks 2015. Neural mechanisms in mechano-transduction and
sensory encoding for Ia muscle spindle afferent fitted to muscle spindle structure
including intrafusal muscle fiber (pink) wrapped by annulospiral ending (green) that
extends unmyelinated followed by myelinated axon. Mechano-transduction involves
mechano-sensitive sodium channels (MSSC) and metabotropic glutamate receptors (MGLUR) that act through a phospholipase D (PLD) mechanism to modulate glutamate
release from synaptic like vesicles (SLV); Sensory encoding mechanisms include BK
and SK potassium channels activated by Ca2+; P/Q and T type Ca2+ channels; and
voltage gated Na+ channels (NaV).
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Chapter III: General Methods
Using in vivo electrophysiology in combination with behavioral analysis, this
proposal will investigate the mechanism(s) underlying acute and chronic forms of OX
neurotoxicity. The general methods utilized are described in detail below.

Animal Use
All animal procedures used are approved by Wright State University Laboratory
Animal Care and Use Committee. Detailed behavioral and electrophysiological analyses
were performed on adult female wistar rats (250-300 g, Charles Rivers Laboratory
Wilmington, VA).

Anesthesia and Vitals
Rats were deeply anesthetized by isoflurane inhalation throughout the entire
terminal experiment, beginning with induction in a closed chamber (5% in 100% O2) and
continuing with delivery via a tracheal cannula (1.5–2.5% in 100% O2). Subcutaneous
injections of lactated ringer solution were given to maintain adequate fluid levels and
blood pressure. Respiratory rate, heart rate, oxygen saturation, and pCO2 were
monitored to ensure anesthesia and overall animal health. Body temperature was
recorded via a rectal probe, and maintained between 36 and 38 °C with heated water
pads and a heat lamp.
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Surgical Technique
Surgical procedures based on Haftel et al. 2004 and Bullinger et al. 2011 (Haftel
et al., 2004; Bullinger et al., 2011b) were used to dissect the hind limb and spinal cord in
order to record afferent firing resulting from electrical stimulation and muscle stretch.
Briefly, the rat was placed in a rigid recording frame, and the legs were placed into
stereotaxis with the knee and ankle joints between 90-120°. The left triceps surae
muscles were isolated via their common Achilles tendon, and resting length was marked
with suture. The tendon was cut at the calcaneus, and the triceps surae was attached to
a force and length-sensing servomotor (Model 305B-LR, Aurora Scientific Inc.) in order
to apply muscle stretches and record length and force changes. Triceps surae nerves
were freed from the surrounding tissue and placed on a unipolar stimulating electrode
(bipolar electrode in some instances), all other hind limb nerves including common
peroneal, sural, and posterior tibial nerves were crushed.

A laminectomy was

performed from T10-S1, and the dura mater was removed to expose the spinal cord and
dorsal roots. Skin flaps were tied up in the back and hind limb to create pools for
mineral oil, in order to prevent the tissue desiccation. During certain experiments ventral
roots were sectioned to eliminate gamma motoneuron influence on muscle spindles.

Recording Preparation/ Data Collection
Dorsal roots were isolated and placed on bipolar recording hook electrodes.
Rootlets were tested for orthodromic action potential volley, and stretch sensitive activity.
Within dorsal rootlets individual sensory axons were penetrated with sharp glass
microelectrodes filled with 2M K+ acetate-. Sensory axons were randomly sampled and
selected for recording when they displayed orthodromic action potentials with a
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conduction delay of < 3 ms following peripheral electrical stimulation of triceps surae
nerves.
Sensory axons were characterized as either muscle spindle or golgi tendon
organ based on response during the rising phase of twitch contractions of the triceps
surae muscles; muscle spindles paused, while golgi tendon organ afferents accelerated
during twitch contraction. Further study of afferent firing was based responses to muscle
stretch including ramp-hold-release (3mm, 20mm/s ramp, 1 sec hold), three successive
triangular stretches (4mm/s, 3mm), vibration (50-250 Hz, 80µm), and ramp-hold-release
(3mm, 20mm/s ramp, 1 sec hold) with superimposed 100 Hz vibration (80µm) during the
1 sec hold phase. Muscle spindle afferents were characterized as primary Ia when they
displayed an initial high frequency burst at the beginning of the ramp or triangular
stretch, 1:1 firing entrainment in response to ≥ 100Hz vibration. Group II muscle spindle
afferents paused firing during twitch contraction but failed to show initial bursting, or 1:1
entrainment to ≥ 100Hz vibration.

All stretches were performed at resting length (Lr) of

10g ± 3g, Lr+ 10g, and Lr+ 20g. Intra-axonal records of action potentials and muscle
length and forced changes were digitized (20 kHz), and stored on a computer for later
analysis using Spike2 software.
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Chapter IV
Specific Aim 1: To test the hypothesis that OX treatment causes proprioceptive
deficits by reducing ionic currents that support sustained repetitive firing
necessary for sensory encoding

Introduction
Previous study of muscle proprioceptors following OX demonstrated an inability
to sustain repetitive firing during static muscle stretch (Bullinger et al., 2011b). It was
determined that the afferents were capable of firing during the time of static muscle by
superimposing high frequency vibration, thus muscle proprioceptors were capable of
firing but just failed to do so in response to static muscle stretch. These results
suggested that OX was impacting the encoding process (Bullinger et al., 2011b). The
loss of sustained firing by muscle proprioceptors is equivalent to a loss of static muscle
length signal to the central nervous system. We predict that this loss of signal will result
in behavioral deficits. One of the primary goals of this proposal is to corroborate the
effect of OX on muscle proprioceptor encoding and to determine how it impacts with
behavior.
The other primary goal of this study is to determine the mechanism(s)
underlying OX disruption of muscle proprioceptor encoding. The effects of OX on hold
phase repetitive firing suggest that OX may be disrupting ionic currents that support
repetitive firing. An inability to repetitively fire suggested a problem with persistent
inward Na+ current (NaPIC) (Lee and Heckman, 2001; Bullinger et al., 2011b; Xie et al.,
2011). NaPIC is essential for repetitive firing in many different groups of neurons:
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motoneurons, cortical neurons, prebotzinger neurons, and large diameter dorsal root
ganglion neurons (Lee and Heckman, 2001; Ptak et al., 2005; Harvey et al., 2006a; Xie
et al., 2011). These currents activate subthreshold causing a subthreshold plateau in
membrane potential that helps limit Na+ channel inactivation during the slow
depolarization at the end of the afterhyperpolarization (Harvey et al., 2006a). If OX is
disrupting NaPIC necessary for sustained repetitive firing then additional signs of
impaired repetitive firing are expected from muscle proprioceptors. We know for
instance, in motoneurons NaPIC role in supporting repetitive firing is dependent on the
speed of depolarization (Harvey et al., 2006a). During slow depolarization, without
NaPIC inactivation of the transient Na+ channel prevails, preventing action potential
formation (Harvey et al., 2006a). Therefore, OX should disrupt repetitive firing during
slow muscle stretch, supporting its role in disrupting NaPIC.
If OX is disrupting a NaPIC necessary for repetitive firing, then pharmacological
agents that block NaPIC injected acutely should reproduce the firing deficits observed
following OX. Riluzole and phenytoin are two drugs that have been shown to block
NaPIC (Zeng et al., 2005; Theiss et al., 2007; Bellingham, 2011; Xie et al., 2011). If OX
is disrupting NaPIC, then riluzole and phenytoin should similarly reduce repetitive firing
in muscle proprioceptors and will provide the first insight into the underlying mechanism
of deficits following OX.
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Methods

Chronic OX Studies
These studies were designed to test effects of chronic OX treatment. Oxaliplatin
(BIOTANG, Lexington, MA) dissolved in 5% dextrose was ad-ministered via
intraperitoneal (i.p.) injection once per week (except week 4 when OX was unexpectedly
unavailable) in single doses of 10 mg/kg to reach a cumulative dose of 70 mg/kg over 8
weeks. Ten female rats received these injections concurrently with five female rats that
served as sham controls receiving only vehicle (5% dextrose i.p.) on the same schedule.
OX effects were assessed by studying rats over a period of 14 weeks spanning periods
before, during and after injections. Throughout this period, each rat was closely and
frequently monitored for pain or distress. No individual rat reached set criteria
established for early removal from the study, e.g. 20% weight loss, vocalization, failure
to drink or groom, severe lethargy, self-mutilation, uncontrollable infection.
Repeated measures of body weight, motor task performance, and tail nerve
conduction were obtained from all rats before electrophysiological recordings were made
in terminal experiments, all as described below.

Behavioral Testing and Other Repeated Measures
Over the course of the study all 15 animals were handled by two individuals who
were responsible for all behavioral testing, weight measurements, SNAP recordings, and
OX treatment. The ladder rung walking task was chosen for its validated use to detect
and describe sensorimotor deficits (Metz and Whishaw, 2002, 2009; Akay et al., 2014).
All 15 rats were introduced and trained on the horizontal ladder run apparatus in a single
session lasting 4 hours one week prior to the start of the study. Rats were trained to
traverse the apparatus in the same direction in order to reach their home cage.
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Behavioral testing was performed once per week at the same time of day on different
days each week, and lasted approximately 4 h. During a test session, each rat traversed
the apparatus 5 times. On separate days animal weight and SNAPs were recorded (see
below). Behavioral sessions were video recorded using a high definition camera
(Samsung F90 HD Camcorder) aimed toward the left side of the animal; a mirror was
placed on the right side of the apparatus to allow clear visibility of the right hind limb (Fig.
1B). All videos were imported onto a laptop computer and exported as QuickTime videos
that were stored for analysis. The person performing all analysis was blinded to which
rats received treatment. All results were compiled and were subsequently decoded for
statistical analyses.

Ladder rung: Horizontal Apparatus
The ladder rung apparatus was built as previously described (Metz and
Whishaw, 2002), consisting of two Plexiglas walls, 1 m × 0.3 m, connected at the bottom
with 1/8 in (~3 mm) diameter steel rods (rungs). Rungs were set at irregular intervals,
with a maximum of 5 cm and a minimum of 1 cm distance between rungs. Holes drilled
for rungs were 1 cm apart, across the entirety of the Plexiglas, allowing for different
iterations (6 iterations were used in total) of rung patterns, preventing animals from
learning any single pattern.

Analysis of Hind Foot Placement
Two measures of hind foot placement: secure placement, and correct placement
were analyzed in control and OX treated animals. All steps taken during ladder walking,
from first to last were included in the analysis (Antonow-Schlorke et al., 2013). Once
analyzed, the data were averaged and are presented as percent of change, week 0
scores were analyzed, averaged and are represented as zero.
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Analysis of Secure Placement
Secure hind foot placement was assessed using the seven-category scale
scoring system introduced by Metz and Whishaw (Metz and Whishaw, 2002, 2009). The
scoring system, which distinguishes misses, slips, and placement errors in rung contact,
was slightly modified by assigning a score of 0 whenever the foot entirely missed a rung,
whether or not it was associated with a deep fall. Based on the scoring system above,
error was defined as a score of 0–2. The total number of errors in hind foot placement
was calculated with no distinction between right and left, and the mean error/step ratio
was calculated for all five trails and represented as percent of error. This number was
multiplied by −1 in order to convert the values into a measure of the number of secure
placements rather than the number of errors per steps. Thus an increase in the number
of errors/steps corresponds to a decrease in secure hind foot placement of the hind foot.

Analysis of Correct Placement
During ladder rung walking, normal rats tended to place their trailing hind foot on
the exact same rung as the ipsilateral front foot, defined here as correct placement of the
hind foot; sequential placement of the ipsilateral hind foot on a different rung was defined
as an error in placement and supposed to reflect impaired proprioceptive ability. Placing
the hind foot on an incorrect rung, and then replacing to the correct rung, was still
considered an error in placement. Correct hind foot placement was defined as the
number of errors/steps multiplied by −1. The total number of errors was counted and
expressed as an average of error/step ratio for both hind limbs. Multiplying this number
by −1 gives a value for correct placement. Thus as the number of errors/ steps
increases, the value for correct hind foot placement decreases.
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Sensory Nerve Action Potentials (SNAPs)
At the end of each behavioral test session, rats were temporarily anesthetized
with isoflurane inhalation via nose cone (2–4% in 100% O2) in order to record SNAPs as
described in our earlier reports (Novak et al., 2009; Bullinger et al., 2011b). Two pairs of
needle electrodes were inserted sub-dermally in the tail: one pair near the base of the
tail for recording SNAPs (compound action potentials) evoked by electrical stimulation
through the other pair located 2 cm distally. A ground electrode was inserted near the
recording electrodes. An electrical stimulus of 10 mA was applied to elicit and record the
SNAP using a Nicolette Viking Quest nerve conduction machine (Natus, Pleasanton,
CA). Before removal of electrodes, a permanent marker was used to re- cord the
position of the electrodes, enabling exact placement of the electrodes for the duration of
the study.

Terminal Experiments
Electromechanical responses of individual proprioceptors were examined
electrophysiologically in terminal experiments performed on all rats, including those used
to study the behavioral effects of OX treatment and those dedicated solely for studying
the acute effects of riluzole and phenytoin on sensory signaling.

Acute Pharmacological Studies
Twenty-two rats having received no prior treatment or study were used to
measure proprioceptor firing responses in terminal electrophysiological study exactly as
described above. Individual muscle proprioceptors were randomly sampled both before
and after i.p. injection of riluzole (16 rats), phenytoin (4 rats), or vehicle alone (DMSO in
saline). Riluzole was given in doses of 4 mg/kg (4 rats), 6 mg/kg (8 rats), and 10 mg/kg

27

(4 rats), and phenytoin was given in a single dose of 20 mg/kg dose. Vehicle consisted
of 1 mL DMSO combined with 4 mL 0.9% saline.

Data Collection from Muscle Proprioceptors
Intra-axonal records from individual muscle proprioceptors were obtained as
described in the general methods section. The parameters recorded from individual
muscle proprioceptors are described next. Dynamic and static responsiveness of
proprioceptors were measured as different parameters of firing occurring, respectively
during changing and constant muscle length. Dynamic response parameters included
rate of initial burst firing at the onset of fast ramp stretches, the rate of firing rates at the
peak of ramp stretch (peak firing rate). Dynamic thresholds were recorded as the length
change necessary to generate sustained repetitive firing during fast and slow ramps.
Measures of static responsiveness were measured during the hold phase of ramp-holdrelease stretches as the duration and average rate of repetitive firing.

Results

Proprioceptive Movement Deficits in OX-treated Rats
In previous study of chronic OX-treatment in rats, we demonstrated defects in
sensory signaling by muscle proprioceptors (Bullinger et al., 2011b). Because these
signals are critical for detecting and guiding limb position and movement, we predicted
deficits in movements that rely on sensory feedback about limb position (see
Introduction). In order to assess sensorimotor function in rats, we tested their
performance in walking over horizontally arranged ladder rungs (Metz and Whishaw,
2002, 2009). As rats move with vision directed forward, success in walking relies on
proprioceptive function that assists with foot placement on rungs that pass out of sight
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(Fig. 3B).
Performance measures in ladder rung walking are illustrated in Fig. 3. All values
are expressed as percent change per rat from scores obtained in early task sessions
(time 0). Plots for secure (Fig. 3A) and correct hind foot placement (Fig. 3C) illustrate
sensorimotor function for each OX-treated rat over time in relation to the mean and 95%
confidence intervals computed from values pooled from all five sham control rats. A
general pattern emerged over time with values for secure and correct hind foot
placement falling below control confidence intervals, despite some tendency for both OX
and control rats to improve performance with time. Divergence from control values
appeared as early as one week after the first OX dose and continued through the last
measurements made 3 weeks after OX-treatment was discontinued.
Closer inspection of Fig. 3 shows the following: First, OX-rats exhibited
considerable variability both among individuals and within individuals across time.
Compare, for example, secure hind foot placement (Fig. 3A) that was poor throughout
and after treatment for OX-rat #3, not distinguishable from normal for OX-rat #5 until
treatment was complete, and never abnormal for OX-rat #2. In this respect, our rat
model reproduces the high degree of variability also observed for the OX patient
population, in which subjective assessment of motor ability varies between and within
individuals (Bennett et al., 2012). Second, Fig. 3A shows that values for secure hind foot
placement in OX-rats rarely exceeded control means and were never higher than the
control 95% confidence intervals. This contrasts with values for correct hind foot
placement (Fig. 3C), which for some OX rats (#4 and #8) were better than normal. Thus,
rats capable of correct placement were unable to make secure contact, e.g. slips
occurred as shown in Fig. 3B. Although these differences between performance in
secure vs. correct hind foot placement may prove to be important if verified in a larger
study, there was nonetheless qualitative agreement between these measures in 7/10 OX
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rats at the time of the last performance measurement (Fig. 3D).
OX-rats were routinely observed for a number of additional factors that might
have contributed to poor sensorimotor performance. Although OX-rats did not increase
body weight as seen in the sham control rats over the study period, both sham control
and OX-rats gained weight. Mean body weight increased 20% for sham controls
compared to 10.5% for OX-rats. Following each treatment, OX rats were also less active
and had lower appetites. Otherwise, OX-rats exhibited no deterioration in general
condition, e.g. severe lethargy, piloerection or failure to groom. During behavioral test
sessions, OX animals exhibited similar climbing and gripping capabilities as control rats.
From the latter observations, we rule out weakness as the basis for poorer than normal
motor performance.
Severe neuropathy, involving dying-back degeneration extending into the
peripheral nerve was assessed by measuring SNAPs from the rats' most distal
extremity, the tail, at the end of each behavioral test session. We found no significant
difference (p > 0.05) between OX and control rats over time consistent with our earlier
study (Bullinger et al., 2011b). Even by the end of behavioral testing, OX-rats were not
different than control, respectively, in either SNAP amplitude (mean ± SD; 0.30 ± 0.04
mV, 0.33 ± 0.08 mV) or latency (mean ± SD; 0.80 ± 0.08 ms, 0.82 ± 0.08 ms). These
findings rule out the occurrence of neuropathy severe enough to cause axon
degeneration in parent sensory nerves, as it does in some though not all OX patients
(Burakgazi et al., 2011). However, this measure does not assess degeneration of the
distal most endings of sensory neurons (see Discussion).

Proprioceptor Impairment Occurred Together with Proprioceptive Movement Deficits
As a test of our hypothesis that proprioceptive encoding deficits contribute to
poor motor performance, we performed in vivo electrophysiological studies on all OX
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treated rats at the conclusion of behavioral evaluation in weeks 12 and 13 (cf Fig. 3A,C
time scale). Analyses focused on Ia muscle spindle afferents, for which per-animal
sample sizes were largest. Fig. 4 compares firing behavior of Ia muscle spindle afferents
sampled from sham control and OX-rats. A conspicuous group difference was found in
static responsiveness, i.e. the firing that occurs during the static (hold) phase of muscle
stretch. Records taken from a control rat (Fig. 4A) show that repetitive firing was
sustained throughout static stretch, which is typical for normal Ia muscle spindle
afferents and which classifies them as slowly adapting sensory neurons (Lewin and
McMahon, 1991). In sharp contrast, records from an OX-rat (Fig. 4B) show that firing
was absent during most of static stretch. The reduction in static responsiveness for OX
rats as a group averaged >50% (Fig. 4D, Table 1). These findings corroborate the
abnormally low static responsiveness that we reported earlier for OX treated rats
(Bullinger et al., 2011b).
The average magnitudes of impairment in proprioceptor signaling and behavioral
performance were compared among individual OX rats. Fig. 4E shows a significant
positive correlation between how securely the hind foot was placed on the rungs and the
duration of Ia muscle spindle afferent static responsiveness (r2 = 0.76, p < 0.01). Static
responsiveness was not significantly related to correct hind foot placement.

Mechanisms of Impaired Proprioceptor Signaling in OX-treated Rats
At the time during static muscle stretch when Ia muscle spindle afferents failed to
fire, superimposition of mechanical vibration, a fast-dynamic muscle stretch was
perfectly effective in eliciting firing (Fig. 4C). Thus, the loss of static responsiveness was
not attributable to inability either to generate or conduct spikes centrally, since the Ia
muscle spindle afferent remained responsive to fast dynamic mechanical stimulation
produced by muscle vibration. Instead we speculated that reduced static responsiveness
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originated from impairment of underlying persistent inward current mechanisms. If this
were the case, then additional signs of firing impairment would be expected, as they are
with suppression of persistent inward currents in other neuronal systems (Harvey et al.,
2006a). Specifically, we expected that the threshold for repetitive firing in OX rats would
remain unchanged during fast ramp stretch (20 mm/s), but would increase during for
slow ramp stretch (4 mm/s). Results illustrated in Fig. 5 confirmed our expectation.
Threshold for repetitive firing increased by about 60% with slow but not fast dynamic
stretch in OX-rats (Fig. 5C,F, Table 1). Comparison of Fig 5A and B provides insight into
the change in threshold. In control rats, repetitive firing is immediately preceded by an
initial burst of rapid firing, which occurs at the onset of fast dynamic stretch and in the
first of three sequential slow dynamic triangular muscle stretches (Fig. 5A; Haftel et al.,
2004). That initial burst was not lost in OX-rats (Fig. 5B), and it occurred at the same
threshold for control and OX-rats (see Table 1). These findings indicate that in OX rats,
increased threshold was specific to repetitive firing and was not an expression of general
insensitivity to mechanical stimulation.

Pharmacological Block of NaPIC Mimics Proprioceptor Impairment with OX
Repetitive firing in response to a static stimulus relies in many neurons on
persistent inward current mediated by Na channels (Crill, 1996; Lee and Heckman,
1998, 2001; Harvey et al., 2006a). If OX treatment altered proprioceptor signaling
through this mechanism, then we expected to mimic its effect by reducing sodium
persistent inward current (NaPIC) in normal rats. Riluzole was selected for its known
effects in blocking NaPIC and repetitive firing in the large diameter class of DRG
neurons that include muscle proprioceptors (Xie et al., 2011).
Fig. 6 illustrates the effect of acute riluzole injection on the static responsiveness
of Ia muscle spindle afferents in normal rats For Ia muscle spindle afferents sampled
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from a single rat, comparison of Fig. 6A with 6B demonstrates a reduction in static
responsiveness similar to that shown for OX treatment (Fig. 4). Fig. 6D demonstrates
that the reduction in static responsiveness was dose dependent. By comparison, OX
reduced static responsiveness by about 60% (Fig. 4; Table 1), an amount found for
riluzole concentrations between 6 and 10 mg/Kg. If we speculate that OX acts through
the same mechanism as riluzole, possibly block of NaPIC, then we would suggest that
NaPIC is only partially impaired by OX treatment.
Additional effects of acute riluzole were studied as they were for OX treatment.
Fig. 6C shows that Ia muscle spindle afferents remained sensitive to fast dynamic
mechanical stimulation produced by muscle vibration, just as in OX-rats (cf. Fig. 4C).
Fig. 7 shows that riluzole increased the threshold for repetitive firing in response to slow
stretches, and affected fast stretches only at the highest dose (cf. Fig. 5 for OX rats).
Table 1 compares riluzole (at the intermediate dose of 6 mg/kg) and OX treatment for
their effects on additional Ia firing parameters. The match is nearly identical between
those parameters that either were or were not significantly different relative to control.
The one exception was peak firing rate which was nominally reduced by riluzole, but not
significantly so as it was with OX treatment. Collectively, these findings are consistent
with the possibility that OX treatment impairs proprioceptor signaling by reducing NaPIC.
Table 1 revealed differences between the control groups for riluzole vs. OX that bear
consideration. Riluzole control values were taken from Ia muscle spindle afferents
sampled from single rats before riluzole injection, and those values are similar to control
values recorded from untreated rats in an earlier study (Bullinger et al., 2011b).
However, the OX controls were different from riluzole controls for nearly every
parameter. We can only speculate that the OX controls were influenced by the
behavioral study protocol or by vehicle injection, nonetheless, these data provide the
appropriate controls for OX treated rats, which underwent the same protocol.
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Riluzole might have reduced Ia static responsiveness through its known action of
blocking NaPIC in motoneurons (Harvey et al., 2006a; Theiss et al., 2007). Through this
action, riluzole might decrease activity of gamma motoneurons, which play a critical role
in setting Ia sensitivity to muscle stretch (Crowe and Matthews, 1964; Matthews, 1972).
To determine whether a loss of gamma modulation of muscle spindle gain might underlie
OX-induced encoding defects, we sectioned ventral roots (where gamma motoneuron
axons exit the spinal cord) and recorded spindle encoding in both controls and riluzole
injected rats. Ventral root section had no significant effect (p > 0.05) on Ia muscle
spindle afferent static responsiveness. In control rats, there was no significant difference
in the duration of static responsiveness with ventral roots intact (746 ± 315 ms) or ventral
roots cut (790 ± 269 ms). Neither did the effect of riluzole depend on gamma
motoneuron input, since riluzole reduced the duration of static responsiveness to levels
that were not significantly different (p > 0.05) with ventral roots intact (423 ± 438 ms) or
cut (518 ± 404 ms).
Mechanistic interpretation of the riluzole effect is confounded by its multiple drug
actions. In addition to blocking NaPIC, riluzole activates calcium dependent potassium
channels (BK/SK) (Grunnet et al., 2001; Wang et al., 2008), inhibits voltage-gated Ca2+
channels (Huang et al., 1997; Stefani et al., 1997), and modulates glutamate signaling
and release (Doble, 1996; Lamanauskas and Nistri, 2008; Bellingham, 2011, 2013), all
of which are present in muscle spindles (Bewick and Banks, 2015). In attempt to narrow
the set of possible explanations for the riluzole effect, we tested acute injection of
phenytoin, which also blocks NaPIC (Lampl et al., 1998; Zeng et al., 2005), but does not
share the other actions with riluzole. The effects of phenytoin on Ia muscle spindle
afferent firing were similar to those of riluzole and OX treatment. Fig. 8 shows the
shortening of firing duration during static muscle stretch described above for OX
treatment and matched to the effect of riluzole at its intermediate dose (6 mg/Kg). The
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reproduction of impaired Ia firing in OX-rats by two drugs having predominantly only
NaPIC blockade in common leads us to the parsimonious though provisional conclusion
that OX reduces static and slow dynamic responsiveness of Ia muscle spindle afferents
by reducing NaPIC in the proprioceptor's peripheral nerve terminals.

Encoding Deficits are Present in Other Muscle Proprioceptors
The large diameter group II muscle spindle afferents and group Ib tendon organ
afferents are also muscle proprioceptors that provide essential feedback regarding
muscle length and force (Matthews, 1972; Jami, 1992). Fig. 9 illustrates the effects of
OX treatment and riluzole on static responsiveness of these two proprioceptors. For
group II proprioceptors, static responsiveness shifted, but only slightly and insignificantly
toward lower than control values in OX rats, although riluzole in the highest dose studied
here produced a substantial and significant decrease. For Ib golgi tendon organ
afferents, there was a significant reduction in responsiveness with OX treatment and
with acute injection of riluzole. This finding had unique value in establishing that impaired
sensory firing did not require the functional and structural specializations that are present
in muscle spindles but absent in tendon organs (Hunt, 1974). We suggest, therefore,
that these findings localize impairment of static responsiveness to the nerve terminals of
proprioceptors.

Discussion

Recently our laboratory discovered that chronic treatment with oxaliplatin in
rodents produces a selective deficit in sensory encoding by muscle proprioceptors
(Bullinger et al., 2011b). In particular, sensory neurons supplying muscle spindle
receptors lose their ability to signal stationary muscle position. Given the primacy of
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proprioceptor signals for informing the central nervous system about limb position
(Prochazka and Ellaway, 2012; Proske and Gandevia, 2012), we predicted, and in the
present study we demonstrated that movements relying on proprioceptive feedback
were impaired in OX-treated rats. This finding motivated us to further explore the cellular
mechanisms underlying impaired sensory signaling. Our findings suggested that OX
treatment chronically impairs proprioceptors through ion-channel mechanisms, which
present possible therapeutic targets for relieving some of the disabling effects of OX
chemotherapy.
Movement Disability with Proprioceptor Impairment
Sensory information provided by muscle proprioceptors is indispensable to the
production of normal movements and postures of body and limbs (Prochazka and
Ellaway, 2012; Proske and Gandevia, 2012). These receptors are distributed in nearly all
mammalian skeletal muscles where they encode dynamic and static parameters of
muscle length and force. Muscle proprioceptors are the major source of sensory
feedback used to control movements that are unassisted by visual input or vestibular
sense, e.g. reaching for an object outside the visual field. Sensory feedback from muscle
proprioceptors is critical not only for making rapid adjustments to unexpected movement
conditions (Nichols et al., 1999; Shemmell et al., 2010), but also for maintaining body
schema, i.e. a sensorimotor representation of the spatial relations between body parts
that is used in guiding voluntary movement (Ivanenko et al., 2011). It follows then that
any conditions which interrupt sensory detection, encoding or signal transmission to the
central nervous system have the potential to result in postural instability, clumsiness,
and ataxia as has been found under a variety of conditions in rodents, cats, and humans
(Krinke et al., 1985; Abelew et al., 2000; Sghirlanzoni et al., 2005).
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In rats receiving chronic OX treatment, we observed abnormal motor behavior
characterized as difficulty with achieving proper limb placement. The following
observations suggest a link to altered proprioceptor signaling. First, the behavioral task
that OX-treated rats struggled with was one that accentuated reliance on proprioceptor
signaling. Specifically, rats walked on ladder rungs, a task that required them to position
hind feet on unevenly spaced rungs that passed outside their visual field as they stepped
forward; rung positions were randomly changed between sessions to prevent advanced
knowledge of their position (Metz and Whishaw, 2002, 2009). This task exposed
substantial errors in placing the foot securely and correctly beginning within the first two
weeks of OX treatment and extending until the last measurements taken at three weeks
after OX treatment. Disability was not attributable to muscle weakness, for which we
found no evidence in the rats' general behavior, e.g. climbing onto objects, or recovering
from missteps or falls on the ladder rung apparatus. Second, the same OX rats that
performed poorly in the proprioceptive movement task also exhibited impaired sensory
signaling in terminal electrophysiological study of muscle proprioceptors. In fact, we
found a significant correlation in the magnitude of abnormalities measured in animal and
proprioceptor behavior. Third, difficulties with limb placement tested in the ladder rung
test are also found in mice in which muscle spindles are selectively eliminated by
experimental genetic mutation (Akay et al., 2014). These observations support a
possible causal relationship between movement disorders and modified proprioceptor
firing observed here for OX treated rats.

Assessing Patient Relevance
With OX chemotherapy, patients report difficulties often characterized as
proprioceptive disability, including instability when walking and clumsiness with
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manipulating objects ((Bennett et al., 2012). There are good reasons to propose that
these movement deficits originate from impaired signaling by muscle proprioceptors. As
muscle proprioceptors are the sole source for detecting and signaling of muscle position
and force in rats and all other mammalian species studied thus far (Matthews, 1972;
Zelena and Soukup, 1983; Jami, 1992), so too are they the origin of this information in
humans. Muscle spindles and tendon organs in humans resemble those in rats and
other animals in their structure and neural innervation (Swash and Fox, 1972; Nitatori,
1988; Eriksson et al., 1994; Liu et al., 2003) and in their encoding of dynamic and static
parameters of muscle conditions, including their sustained (slowly adapting) firing during
fixed muscle length or force (Edin and Vallbo, 1990a, b, c; Macefield, 2005).
Experimental manipulations of proprioceptor signaling in humans, e.g. temporarily
silencing muscle proprioceptors by nerve compression (Walsh et al., 2010; Inui et al.,
2011) demonstrate their necessity for normal movement. Additionally, destruction of
muscle proprioceptors in human victims of large fiber neuropathy leads to clumsiness,
ataxia and inability to properly position limbs outside visual field (Rothwell et al., 1982).
These observations establish strong parallels between humans and another animal
species with respect to proprioceptor signaling and its requirement in producing normal
movement, and they support our assertion that the effects of OX on proprioceptive
signaling and behavior that we observe in rats are likely to have relevance for patients.

Role of Neuropathy
Signaling by primary sensory afferents might be obstructed through any one of
several processes and locations, ranging from sensory detection or encoding at afferent
endings to conduction and transmission by afferent axons and central synapses. The
best documented cause of chronic sensory impediment by OX chemotherapy is
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neuropathy, occurring as a length-dependent dying back from the distal ends of the
longest sensory axons supplying distal limbs, e.g. feet and hands (Avan et al., 2015).
The possibility that neuropathy contributed to present results cannot be definitively
discounted. Although we found no evidence of neuropathy in SNAPs measured from the
long sensory axons in the rat tail, we did not directly test for histological signs of
degeneration in sensory nerve terminals. While acknowledging uncertainty, the following
several observations suggested to us that neuropathy was probably not a major
contributor to our results. First, none of the proprioceptors sampled from OX rats
generated action potentials in response to electrical stimulation of nerve (1 cm proximal
to muscle entry) without also firing in response to muscle stretch, thereby giving no
evidence that sensory terminals had degenerated in advance of parent axons. Second,
direct histological examination in our earlier study showed that the sensory innervation of
muscle spindles was not retracted and was grossly normal in appearance (Bullinger et
al., 2011b). It is important to note, however, that the cumulative dose of OX was raised
from 40 mg in that previous study to 70 mg in the present study, in order to better match
the dosage in humans. A cumulative dose of 70 mg/kg in rats is equivalent to
approximately 415 mg/m2 in humans (Freireich et al., 1966; Reagan-Shaw et al., 2008),
a dose that is at just threshold for the earliest detection of neuropathy measured from
changes in SNAP amplitude (Grothey, 2003) and well below levels, >700 mg/m2, that
produce robust neuropathy (Argyriou et al., 2008; Avan et al., 2015). Thus we may not
expect the higher dose used in the present study to produce substantially more
neuropathy in our OX treated rats, and this supposition is supported by the similarity in
OX effects on the mechano-responsiveness of proprioceptors sampled in this and our
previous study (cf Table 1 from each paper). Third, the chronic effects of OX were
stereotypical in affecting static firing exclusively and did not express widely varying
changes in firing behavior that one would expect from individual proprioceptors in
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different stages of sensory terminal degeneration. None of these observations are easily
reconciled as evidence for neuropathy.
While evidence for neuropathy in patients is in many cases incontrovertible and
undoubtedly a significant contributor to disability (Argyriou et al., 2014; Avan et al.,
2015), additional chronic effects and their importance cannot be dismissed. For
example, pain and allodynia observed following OX (Kiernan, 2007; Fehrenbacher,
2015) are suspected to result, not from neuropathy, but instead from sensory axon
hyper-excitability (Park et al., 2009a, 2011b). Neither does neuropathy explain disability
reported by patients for whom there is no evidence for a decrease either in SNAPs or in
the density of epidermal nerve terminals (Burakgazi et al., 2011). When significant
neuropathy does occur, it may not act alone in causing disability. Considering the
possibility that OX affects proprioceptor signaling in patients, as we show here for
rodents, we expect involvement of proprioceptors distributed throughout the body.
Proprioceptors reside in trunk and proximal limbs muscles (Banks, 2006), and the
sensory feedback they supply supports sundry movements and postures (Proske and
Gandevia, 2009; Roden-Reynolds et al., 2015). Normal walking, for example, relies
heavily on sensory feedback from proprioceptors in hip muscles (Roden-Reynolds et al.,
2015). Impaired signaling from those sites would be readily capable of contributing to
imbalance, difficulty walking, and clumsiness variously described by OX patients. These
proximal origins of movement disability originating proximally would be masked,
however, and mistakenly assigned to proprioceptors in distal extremities denervated by
length-dependent neuropathy, because we commonly interact with the environment
through hands and feet. Sensation from the feet is critical for weight bearing activities
(Meyer et al., 2004) and from hands for skilled grasping (Witney et al., 2004). All
considered, it seems reasonable, and not disproven that factors in addition to distal
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neuropathy contribute significantly to chronic disability. This notion could be critically
assessed by discriminating tests for proprioceptive disorders in the trunk, shoulders and
hips.

A Mechanism for OX Modification of Proprioceptor Encoding
Several mechanisms apart from neuropathy might have resulted in selective
modification of static firing by proprioceptors following OX treatment. Reduced static
firing might have derived from one or another of the numerous specializations of muscle
spindle receptors. For example, OX might have impaired static firing by reducing gamma
motor drive to the spindle's intrafusal muscle fibers (Matthews, 1962; Boyd and Ward,
1975; Banks et al., 1997). This possibility seemed unlikely, however, given our
demonstration that complete experimental elimination of gamma motor input was not
capable of significantly reducing proprioceptor responsiveness. More generally, we were
able to rule out the necessity of specializations unique to muscle spindles by
demonstrating that static responsiveness was equally impaired in Ib proprioceptors that
provide the sole neural innervation to relatively non-specialized tendon organ receptors
(Hunt, 1974; Jami, 1992; Zelena, 1994). The proprioceptors' parent axons, spanning the
distance from muscle to dorsal roots, were fully competent to generate and conduct
action potentials from nerve terminals to the spinal cord, even at sustained, high
frequency in response to rapid oscillations in muscle length, i.e. vibrations. Finally, the
generation of action potentials with high fidelity in response to each length oscillation
throughout bouts of muscle vibration demonstrated that the underlying ionic currents
generated either in mechano-transduction or in action potential encoding were not
chronically disabled by OX (Bewick and Banks, 2015). Elimination of these mechanisms
promoted the idea that abbreviated static responsiveness and increased threshold for
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repetitive firing involved sustained ionic currents and channels normally generated
during static and dynamic muscle stretch. The suspect channels are ones that contribute
to currents underlying the receptor potential produced through mechano-transduction
(Hunt et al., 1978) and/or currents required to sustain repetitive firing of action potentials
for encoding steady depolarization.
The ion channels that support sustained repetitive firing during steady
depolarization in muscle proprioceptors have not been identified. In numerous other
neurons, repetitive firing to sustained and slow depolarization rests on properties of Na+
channels that inactivate slowly and thus generate persistent inward currents (NaPIC)
(Crill, 1996; Lee and Heckman, 1998, 2001; Harvey et al., 2006a). One of these
channels, NaV1.6 is expressed by large diameter DRG neurons (Black et al., 1996;
Rush et al., 2007; Chung et al., 2015), which include muscle proprioceptors as well as
primary sensory neurons supplying skin. Expression of NaV1.6 by the cell body is
matched by expression in the nerve terminals of Merkel cells (Lesniak et al., 2014),
which like proprioceptors are slowly adapting (Iggo and Muir, 1969; Zimmerman et al.,
2014). Furthermore, both NaV1.6 and NaPIC respond acutely to OX (Sittl et al., 2012).
Collectively, these findings led us to predict that OX might abbreviate static
responsiveness and increase the dynamic threshold of for repetitive firing by
compromising NaPIC in the nerve terminals of proprioceptors.
We assessed the importance of NaPIC by testing whether a known
pharmacologic antagonist would mimic the OX effect on static responsiveness and the
dynamic threshold for repetitive firing. We selected riluzole for its action as a blocker of
NaPIC (Benoit and Escande, 1991; Urbani and Belluzzi, 2000; Lamanauskas and Nistri,
2008; Bellingham, 2011) in DRG neurons (Xie et al., 2011). Acute i.p. injection of riluzole
in normal rats reproduced essentially all of the effects that chronic OX had or did not
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have on proprioceptor encoding. While having no effect on the normal generation or
conduction of action potentials evoked by muscle vibration, riluzole exhibited a dose
dependent reduction in static responsiveness. Riluzole also increased repetitive firing
threshold during slow ramps as it did in OX treated rats, and at higher doses increased
repetitive firing threshold during fast ramps. These findings supported our hypothesis,
however, riluzole's additional drug actions, e.g. activation of K+ current via BK channels
(Grunnet et al., 2001; Wang et al., 2008) confound interpretation. Although there is as
yet no more specific NaV1.6 antagonist, there is anti-epileptic drug, phenytoin, which
shares only riluzole's block of NaPIC, but none of its other drug actions (Lampl et al.,
1998; Zeng et al., 2005). Previous study has established that in cats, phenytoin reduced
the static responsiveness of muscle spindles (Anderson and Raines, 1974). Our finding
that acute administration of phenytoin to normal rats also abbreviated static
responsiveness bolsters the plausibility that NaPIC supports static firing in
proprioceptors and that it may be the target of chronic OX.
The route by which chronic OX treatment might compromise NaPIC remains to
be determined. Some studies (Sittl et al., 2012) though not all (Wu et al., 2009)
demonstrate that OX acutely increases and prolongs NaPIC in DRG neurons. In
addition, NaV1.6 provides a route through which mechanical allodynia develops,
presumably from increased excitability of large diameter sensory neurons, within 24 h of
intra-plantar injection of OX in mice (Deuis et al., 2014). These acute effects of OX are
opposite to the decreased excitability we observe in muscle proprioceptors. We did find,
however, that acute administration of high doses of OX produced spontaneous firing in
normal rats, and we are currently testing whether this acute increase in excitability might
trigger a compensatory and chronic decrease in excitability. If this is the case then
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blocking acute hyper-excitability is a potential treatment that may prevent chronic effects
on proprioception.

Conclusion
Our findings demonstrate that oxaliplatin treatment has the potential to cause
chronic movement disorders by a novel mechanism. In our rodent model of OX
neurotoxicity, movement deficits in tasks relying on proprioception co-existed with
impaired sensory encoding that selectively diminished the signal for static or slowly
changing muscle position. We suggest that proprioceptor signaling is diminished by a
chronic effect of OX that impairs NaPIC. Identification of this independent target of OX
neurotoxicity offers a novel target for therapeutic intervention.
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Fig. 3. Movement disability in OX-treated rats. Rats were scored for errors in hind
foot placement while walking on unevenly spaced ladder rungs in sessions spanning 11
weeks. (A, C) For untreated control rats (n=5) data were pooled and plotted as percent
change in order to illustrate improvement (training effect) relative to initial task sessions
(time 0); mean values (open black circles joined by lines) are bracketed for 95%
confidence interval (CI). For each one of 10 OX-treated rats (identified by red number)
mean percent change is plotted per task session, and the schedule for OX injection is
noted by blue dots. (A) Secure hind foot placement was scored by errors/steps in rung
contact multiplied by -1 and computed as percent change from the pre-treatment value
for each OX treated rat. (B) Photograph shows left hind limb slip in double image
(simultaneous side and underneath views) of OX-treated rat walking on ladder rungs. (C)
Correct hind foot placement was scored by errors/steps in correctly placing the trailing
hind foot on the same rung as the ipsilateral forelimb multiplied by -1 and computed as
percent change from the pre-treatment value for each OX treated rat. (D) Plot of secure
vs. correct hind foot placement (unlike Figs. 1A and 1C, values were calculated as
percent change from untreated control mean value at week 11); box at origin
encompasses variation pooled for untreated control rats.
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Fig. 4. OX treatment shortens firing duration during static muscle stretch.
Representative records of Ia muscle spindle afferents firing (grey traces show intraaxonal records of action potentials, black dots indicate instantaneous firing rate) in
response to ramp-hold-release muscle stretch (B bottom trace; 3 mm, 20 mm/s, 1 s hold
phase). (A) In an untreated control rat, Ia fired during fast-dynamic (ramp) phase and
throughout static (hold) phase of stretch. (B) In a rat 4 weeks after 8-week treatment
course of OX, Ia fired similar to normal during fast- dynamic phase but stopped firing
during the static phase of muscle stretch. (C) For the same Ia muscle spindle afferent as
in B, vibration superimposed on muscle stretch (bottom trace; 100 Hz, 80 µm vibration
during stretch hold phase) restored firing. (D) Mean± SE for duration of static-phase
firing expressed as percent change for pooled samples of Ia muscle spindle afferents in
OX-treated rats (71 Ia's in 10 rats) relative to control rats (52 Ia's in 5 rats). (E)
Comparison of mean static-phase firing (n > 4 Ia muscle spindle afferents per animal)
and secure hind foot placement for individual control (C) and OX (OX) animals
expressed as a percent change from mean control values. Secure hind foot placement
during horizontal ladder rung task is positively correlated with the duration of static
responsiveness (r2 = 0.76, p < 0.01, dashed line).

48

49

Fig. 5. OX-treatment increases repetitive firing threshold during slow- but not fastdynamic muscle stretch. Threshold for repetitive firing was measured from Ia muscle
spindle afferents during fast ramps (20 mm/s; left column) and slow ramps (4 mm/s in 3
successive triangular stretches; right column). Action potential firing and firing rate in
response to muscle stretch (traces described in Fig. 4) were taken from one Ia muscle
spindle afferent in a control rat (A) and one in an OX-treated rat (B). Repetitive firing
threshold (arrow heads) after OX-treatment was similar to control for fast ramps, but
higher than control for slow ramps. Note that threshold of the transient initial burst was
unchanged. (C) Mean ± SE for repetitive firing threshold for fast (left) and slow (right)
ramps expressed as percent change for pooled samples of Ia muscle spindle afferents in
OX- treated rats (58 Ia's in 10 rats) relative to control rats (51 Ia's in 5 rats).
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Fig. 6. Riluzole mimics OX-treatment in shortening firing duration during static
muscle stretch. Representative records (as described in Fig. 4) of Ia muscle spindle
afferent responses to muscle stretch in one rat studied (A) before and (B) after Riluzole
injection (6 mg/ kg i.p.). Similar to the effect of OX-treatment (Fig. 4), acute Riluzole
injection shortened static responsiveness, but had no apparent effect on dynamic
responsiveness exhibited during fast-ramp stretch or vibration (C). (D) Reduction in
duration of static responsiveness (expressed as percent change from control) for Ia
muscle spindle afferents was dose dependent.
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Table 1. Muscle length encoding by Ia muscle spindle afferents. Rats in oxaliplatin
(OX) study were all subject to the same procedures, i.e. chronic measurement of motor
performance and terminal measurement of proprioceptor encoding; 10 received
repeated injections of vehicle + OX and 5 received injections of vehicle alone. All rats in
riluzole (Ril) study, were examined only in terminal experiments to obtain measurement
of proprioceptor encoding before and after Ril injection. n, number of afferents pooled
within groups. Nested ANOVA and Tukey’s post hoc tests were used to test for the
significance of group differences. * P < 0.05
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Fig. 7. Riluzole mimics the OX-treatment increase in repetitive-firing threshold
during slow-dynamic muscle stretch. Representative records of Ia muscle spindle
afferent firing in response to muscle stretch (cf. Fig. 3) in a rat studied (A) before and (B)
after riluzole injection (6 mg/kg i.p.). Repetitive firing threshold (arrow heads) was similar
before and after acute Ril injection for fast ramps, but was substantially higher for slow
ramps. Note that threshold of the transient initial burst was unchanged. (C) Mean ± SE
repetitive firing threshold for fast (left) and slow (right) ramps expressed as percent
change for pooled samples of Ia muscle spindle afferents after relative to before Rilinjection.
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Fig. 8. Phenytoin shortens firing duration during static muscle stretch. (A)
Representative records of a Ia muscle spindle afferent firing (top grey trace action
potentials with instantaneous firing rate indicated by superimposed black dots) in
response to ramp-hold-release muscle stretch (bottom trace; 3 mm, 20 mm/s, 1 s hold
phase) following phenytoin injection (20 mg/kg i.p.). Similar to the acute effect of riluzole
(cf Fig. 4), acute phenytoin injection shortened static responsiveness, but had little effect
on dynamic responsiveness exhibited during fast-ramp stretch or vibration (data not
shown). (B) Duration of static responsiveness (expressed as percent change from
control) significantly reduced for 25 Ia muscle spindle afferents measured in rats injected
with phenytoin compared with 21 Ia muscle spindle afferents in control rats.

58

59

Fig. 9. Effects of OX treatment and riluzole on group II spindle and Ib tendonorgan proprioceptors. (A) OX treatment shortened firing duration during static muscle
stretch nominally for II's (p = 0.077) and significantly for Ib's. (B) Acute riluzole injection
also tended to shorten firing at the highest doses
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Chapter V

Specific Aim 2: To test the hypothesis that 5-HT2 agonists, that increase
persistent inward currents, can restore sensory encoding by muscle
proprioceptors following OX.

Introduction

Aim one establishes that chronic OX impairs a NaPIC necessary for sustained
repetitive firing during normal proprioceptor encoding. This current localizes to the
receptor terminal and offers a novel therapeutic target to restore proprioceptor encoding.
Recent work has identified the Na+ channel subtypes present at the sensory nerve
terminal. Consistent with NaPIC playing a role in encoding, NaV 1.6 has been identified
at the sensory nerve terminal of muscle proprioceptors (Carrasco et al., 2017). NaV 1.6
has been shown in large diameter dorsal root ganglion neurons to mediate a large
NaPIC, suggesting that it may be performing a similar task at the sensory nerve terminal
(Rush et al., 2007). Targeting this current might restore repetitive firing lost in muscle
proprioceptors following OX.
NaPIC’s role in repetitive firing has been well established in numerous types of
neurons (Crill, 1996; Lee and Heckman, 2001; Harvey et al., 2006a; Perrier et al., 2013).
The subthreshold NaPIC is thought to arise from the same transient Na+ channels that
underlie action potentials (Alzheimer et al., 1993). The majority of voltage-gated Na+
channels carrying the transient Na+ current underlying action potentials rapidly inactivate
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after an opening period. A small number of these channels likely 1-3% enter a
persistent state, giving rise to NaPIC (Alzheimer et al., 1993).
In motoneurons, 5-HT and serotonergic agonists increase the amplitude of
NaPIC (Harvey et al., 2006b; Murray et al., 2010; Murray et al., 2011). 5-HT2 receptor
activation in motoneurons that are unable to repetitively fire during slow current injection
led to robust repetitive firing that correlated with large increases in NaPIC (Harvey et al.,
2006b). 5-HT2 receptors are coupled to the Gαq-protein, which through activation of
phospholipase C, increases DAG, and IP3(Harvey et al., 2006b; Murray et al., 2011).
PKC is known to phosphorylate Na+ channels altering their activation and inactivation.
Furthermore, PKC has been show to facilitate NaPIC ((Franceschetti et al., 2000).
In order to determine the feasibility of therapeutic restoration of proprioceptor
encoding, a non-specific 5HT-2 receptor agonist quipazine was chosen (Chopek et al.,
2013). Quipazine was given in terminal experiments following injection with 6 mg/kg
riluzole. In the acute setting quipazine improved proprioceptor encoding, this suggested
that encoding following OX could be restored. Following chronic OX treatment, a FDA
approved 5-HT2C receptor agonist (Witkamp, 2011), lorcaserin was tested. The switch
to lorcaserin was necessary to establish the potential for translation to human studies
with an FDA approved drug.

Methods

All surgical procedures and data collection in this aim are the same as the
studies outlined above in general methods and specific aim 1 methods.
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Acute Pharmacological Studies
Rats previously untreated were used to measure proprioceptor responses in
terminal experiments as described in general methods. Ten animals were used to
assess the effects of quipazine on muscle proprioceptors impaired by riluzole. In these
animals muscle proprioceptors were sampled before and after i.p. injection of riluzole (6
mg/kg), followed by sampling after i.p. injection of quipazine (10 mg/kg). In five of these
animals ventral roots were sectioned prior to any recording to remove any influence of
gamma motoneurons on muscle spindle function. Riluzole injections were handled as
described in aim 1. Quipazine, 10mg, was dissolved in 1 ml DMSO and 4 ml 0.9%
saline and dose by animal body weight (mg/kg).

Chronic OX Studies
In the same animals that underwent chronic OX treatment in specific aim 1, three
animals were selected for further study with lorcaserin. Muscle proprioceptors were
sampled prior to i.p. injection with lorcaserin, 2 mg/kg. Lorcaserin, 10 mg, was dissolved
in 0.9% normal saline and was dosed based on animal body weight (mg/kg). Following
collection of muscle proprioceptor responses following lorcaserin, ventral roots were
sectioned and sampling continued.

Results

Chronic OX impairs muscle proprioceptor encoding by disrupting a novel NaPIC,
leading to behavioral deficits. Identification of this underlying mechanism allows for
application of a targeted therapeutic to potentially restore muscle proprioceptor encoding
and behavior. If successful in the rodent, this therapeutic would have the potential to
translate to human studies and significantly improve patient lives.
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Quipazine restores Ia muscle spindle afferent responsiveness after riluzole
In other neuronal subtypes, NaPIC can be increased by activation of 5-HT2
receptors. We applied two different 5-HT2 receptor agonists after either acute riluzole or
chronic OX. In the acute study, a dose of 6mg/kg riluzole was chosen because it most
closely matches the effects of chronic OX on muscle proprioceptor encoding, specifically
Ia muscle spindle afferents. Following acute injection of 6 mg/kg riluzole 68% of
sampled 1a muscle spindle afferents fail to fire at least 800 ms of a 1000 ms hold phase,
compared to only 25% in control conditions. This drastic loss of sustained repetitive
firing represents a significant loss of muscle length and force feedback to the central
nervous system.
Within individual animals treated with riluzole, quipazine dramatically improved
repetitive firing in Ia muscle spindle afferents.

Fig. 9 compares static responsiveness

duration for control, 6 mg/kg riluzole, and 10 mg/kg quipazine. Riluzole (6 mg/kg)
significantly reduces sustained firing, and following i.p. injection of quipazine there is a
significant (p<0.05) increase in static responsiveness. After quipazine, only 33% of Ia
muscle spindle afferents failed to fire at least 80% through the hold phase, compared to
68% in riluzole 6 mg/kg. This marks a significant restoration of sustained repetitive firing
during static muscle stretch and therefore fixed muscle position and force feedback to
the central nervous system. This effect was rapid and occurred within 45 min of injection
and lasted for hours following injection.
Quipazine’s ability to increase the duration of static responsiveness restores part
of the signal lost following treatment with riluzole. Characteristic of disrupting NaPIC,
riluzole also selectively disrupts repetitive firing during slow dynamic stretch, measured
by an increase in the repetitive firing threshold (slow dynamic threshold). Similar to
impaired repetitive firing during sustained muscle stretch, the loss of repetitive firing
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during muscle stretch represents a significant loss of feedback regarding changing
muscle length and force to the central nervous system. Fig. 10 compares slow dynamic
threshold in control rats, and those treated with riluzole and quipazine. The increase in
slow dynamic threshold by riluzole was corrected by quipazine. In fact quipazine
reduced slow dynamic threshold to less than that observed in controls. Thus, quipazine
increased repetitive firing deficits during slow muscle stretch, restoring the lost feedback
to the central nervous system.

Lorcaserin Restores Ia Muscle Spindle Afferent Responsiveness after OX
Similar to riluzole (6 mg/kg), following chronic OX 73% of Ia muscle spindle
afferents sampled failed to fire at least 800 ms during a 1000 ms hold phase. The
similar effects of riluzole and chronic OX on static responsiveness suggest that
quipazine or other 5-HT2 agonists should restore firing following chronic OX. Due to the
translational implications of restoring proprioceptor encoding following chronic OX, the
FDA approved 5-HT2C receptor agonist lorcaserin was chosen (Witkamp, 2011). Fig. 11
shows the effects of lorcaserin on the duration of static responsiveness. Similar to
quipazine, lorcaserin (2 mg/kg) significantly increased the duration of static
responsiveness. After lorcaserin only 40% of Ia muscle spindle afferents failed to fire at
least 800 ms during a 1000 ms hold phase. The effect was not as robust as the 5-HT2
nonspecific agonist quipazine given in the acute setting with riluzole, but was still
capable of restoring a significant amount of encoding and therefore muscle length and
force feedback after chronic OX.
In order for lorcaserin to have potential as a target treatment following OX it
should also significantly reduce the slow dynamic threshold. Fig. 12 compares the slow
dynamic threshold in control, OX, and following lorcaserin. Fig. 12A is a representative
record following chronic OX increasing the slow dynamic threshold. Fig. 12 B is from the
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same animal following injection with lorcaserin (2 mg/kg), and shows the reduction in
slow dynamic threshold. Again, the results with lorcaserin were not as robust as those
with riluzole, but clearly showed a significant effect on slow dynamic threshold following
OX.
Our conclusions from aim 1 suggest that chronic OX is most likely disrupting a
NaPIC necessary for muscle proprioceptor encoding. The presence of NaPIC in muscle
proprioceptors is novel and any regulation at this level is unknown. NaPIC in other
neuronal systems is regulated by Gq-coupled 5-HT2 receptors (Harvey et al., 2006b;
Murray et al., 2011). The next step is to determine how quipazine and lorcaserin are
working to restore encoding specifically in Ia muscle spindle afferents. There are two
potential locations where these drugs could be working, either peripherally at the spindle
terminal, or centrally likely by increasing output from gamma motoneurons. As
mentioned in the background section, muscle spindles receive both sensory and motor
innervation. The motor innervation arises from gamma motoneurons, which can be
further broken down in to static and dynamic, based on their effects on either static or
dynamic responsiveness (Boyd and Ward, 1975; Banks et al., 1997).
In order to determine where quipazine and lorcaserin were acting to restore
encoding, ventral roots were sectioned either prior to any recording in the case of
riluzole or following injection of the 5-HT2 agonists in the case of chronic OX. If the
selected 5-HT2 agonists are working peripherally, then ventral root section should have
no effect on their ability to restore encoding. If they are working centrally, ventral root
section should eliminate their effects.
Fig. 13 shows the effects of ventral root section on the effectiveness of quipazine
and lorcaserin to increase the duration of static responsiveness. Note, that in the case
of quipazine, ventral roots were sectioned prior to any recording and riluzole injection.
As discussed in aim 1 ventral root section had no effect on encoding in control or riluzole
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treated afferents. In OX animals ventral roots were sectioned following injection and
data collection with lorcaserin. In the case of riluzole and quipazine (Fig. 13A) ventral
root section eliminates the efficacy of quipazine to restore static encoding. With
lorcaserin (Fig. 13B) the trend is similar, but did not reach significance. This is likely
because the effectiveness of lorcaserin to restore static responsiveness was less than
that of quipazine, however a peripheral effect of lorcaserin cannot be ruled out.
Ventral root section showed similar effects on slow dynamic threshold following
5-HT2 agonist injection. Acutely, eliminating motor influence significantly reversed the
effectiveness of quipazine to decrease the slow dynamic threshold. The same results
were observed with ventral root section after lorcaserin. Unlike the effects of ventral root
section on static responsiveness, ventral root section after lorcaserin significantly
increased slow dynamic threshold. This difference most likely arises from the fact that
lorcaserin had a larger effect on slow dynamic threshold than the duration of static
responsiveness.

Discussion
Disruption of NaPIC by chronic OX significantly impairs muscle proprioceptor
encoding resulting in behavioral deficits. The largest effect was on Ia muscle spindle
afferents, and so in aim two, known 5-HT2 receptor activators were applied. In the acute
setting following riluzole and after chronic OX 5-HT2 agonists significantly increased
repetitive firing and were able to restore encoding in Ia muscle spindle afferents. Overall
lorcaserin was less effective in restoring proprioceptor function. This may result from
lorcaserin being a specific activator of 5-HT2C receptors, whereas quipazine is nonspecific. Ventral root section eliminated the effects of 5-HT2 receptor agonists on
impaired muscle proprioceptors encoding, suggesting that their actions were central.
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Localizing the Actions of Quipazine and Lorcaserin
Results following ventral root section point to a central mechanism for quipazine
and lorcaserin. The most likely explanation is that quipazine and lorcaserin increased
output from gamma motoneurons, which extrinsically modulate muscle spindle afferent
discharge (see section II). The effectiveness of both drugs to restore dynamic and static
responsiveness suggests that they increased output from both static and dynamic
gamma motoneurons.
Gamma motoneurons are smaller than alpha motorneurons, which in part
explains their different membrane properties (Jankowska et al., 1998; Enjin et al., 2012).
Despite these differences gamma motoneurons show similar firing frequencies when
compared to alpha motoneurons (Jankowska et al., 1998; Enjin et al., 2012). Given that
gamma motoneurons must generate repetitive trains of action potentials like alpha
motoneurons, it is likely that they express voltage-gated Na+ channels that carry a
NaPIC. It is likely that NaPIC in gamma motoneurons is also modulated by 5-HT2
receptors.
5-HT1D has been identified as a novel marker for gamma motorneurons (Enjin et
al., 2012), but there is no available data on the expression of 5-HT2 receptors. Previous
studies have established that serotonin precursors (5-HTP) increase firing in gamma
motoneurons (Ellaway and Trott, 1975; Myslinski and Anderson, 1978; Djupsjobacka et
al., 1995; Jankowska et al., 1998), suggesting that serotonin receptors increase their
output. This occurs in two different ways, by directly activating 5-HT receptors on
gamma motoneurons and/or by reflex activation of gamma motoneurons mediated most
likely by chemosensitive group III and IV muscle afferents (Djupsjobacka et al., 1995).
Based on the similarities of alpha and gamma motoneurons 5-HT2 agonists likely
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increase output by increasing PIC. Although the exact mechanism of gamma
motoneuron activation by quipazine and lorcaserin is not discernable based on our
results, they significantly improve muscle proprioceptor encoding impaired by riluzole
and OX.

Functional Considerations
Gamma motoneuron input modulates muscle proprioceptor output in a task
dependent manner (Prochazka and Ellaway, 2012). There several different supported
theories of how and when gamma motoneurons fire during movement: alpha-gamma coactivation, tonic- phasic gamma activation, fusimotor set, and forward sensory models
(Taylor et al., 2006; Prochazka and Ellaway, 2012; Ellaway et al., 2015). Evidence for
all of these theories have been identified in both animal and human studies. As
described by its name alpha-gamma co-activation occurs when gamma motoneurons
are activated in sync with alpha motoneurons. In this model gamma firing keeps the
muscle spindles in a sensitive state to detect unexpected length changes, evidence for
which has been found using microneurography (Burke et al., 1978; Aniss et al., 1990;
Murphy and Martin, 1993; Kakuda et al., 1996). Other studies in cats favored a tonic
phasic activation of gamma motoneurons. In this model static gamma motoneuron
discharge is relatively tonic suggesting that group II afferent firing was a temporal
template of the intended movement, while dynamic gamma discharge is phasic and
occurs just prior to the transition from muscle shortening to lengthening (Taylor et al.,
2000b; Taylor et al., 2000a; Taylor et al., 2006). This would sensitize Ia muscle spindle
afferents to the beginning of muscle stretch. Similar to tonic- phasic gamma activation,
fusimotor set suggests that there is tonic firing from static gamma motoneuron and that
dynamic gamma activity was modulated in an activity dependent manner (Prochazka et
al., 1985). Lastly forward sensory models are a recent development based on
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microneurography in humans that showed that muscle spindle firing reflected muscle
length changes, muscle contraction, and was predictive of future movements (Dimitriou
and Edin, 2010). The wide variety of evidence for gamma motoneuron function
suggests that their output to muscle spindles is linked with activation of alpha
motoneurons, and dependent on the motor task (Prochazka and Ellaway, 2012).
Given the large functional impact on muscle spindle output, gamma motoneuron
discharge may be able to compensate for impaired encoding following OX. This idea is
supported by our results above, which suggest that increased gamma motoneuron
output compensates for the encoding deficit following OX. However, this result is
complicated by the fact that in our in vivo preparation, gamma motoneuron output is
suppressed by anesthesia (Matthews, 1963; Haftel et al., 2004). It is evident from aim 1
that suppressed or eliminated gamma motoneuron input is not responsible for the
impaired encoding deficit following OX. It may be possible however that the encoding
deficit we observe would not be present in awake freely moving animals because of
intact and physiologic gamma motoneuron output. Following chronic OX animals
showed significant behavioral deficit and the severity of behavioral deficit was highly
correlated with the amount of impaired encoding. This suggests that either normal
gamma motoneuron output is not able to compensate for impaired encoding, or chronic
OX also impairs repetitive firing in motoneurons. Regardless of which of these is the
case, both would be significantly improved by increasing NaPIC and therefore repetitive
firing.
While direct study of motorneurons following OX has not been done, recent
clinical studies have highlighted motor deficits in patients following chronic OX. For
example, following OX patients describe that their “legs feel heavy, like pulling a couple
of logs around” (Bennett et al., 2012). These testimonials are corroborated by other
studies describing fatigue and increased fall risk in patients following OX (Burakgazi et
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al., 2011; Tofthagen et al., 2012; Kneis et al., 2015; Taleb et al., 2017). This may result
from impaired motoneuron firing, potentially due to a decrease in NaPIC. Reduced
NaPIC in motoneurons has been shown to be an important contributor to weakness and
fatigue following sepsis (Nardelli et al., 2016). If alpha motoneuron repetitive firing is
disrupted following chronic OX, then it is possible that gamma motoneurons may be
similarly affected. An effect on gamma motoneurons would compound muscle spindle
dysfunction. This suggests that lorcaserin could potentially restore muscle spindle
feedback and alleviate weakness and fatigue following chronic OX.

Optimal Therapeutic Target
Results from aim 1 identified an encoding problem intrinsic to muscle
proprioceptors that as shown above, can be fixed by extrinsically likely by increasing
gamma motoneuron discharge. As discussed above patients also have motor
symptoms following OX, suggesting that there might be a problem intrinsic to the
motoneurons. Preliminary studies from our laboratory support the idea that following
chronic OX motoneurons also have trouble repetitively firing (data not shown). This
finding is similar to that in motorneurons following sepsis, which is thought to result from
decreased NaPIC (Nardelli et al., 2016). While 5-HT2 agonists would likely correct this
issue, which then as suggested by results in this aim would restore encoding in muscle
proprioceptors, a more effective treatment would be to target NaPIC in each location. As
mentioned regulation of NaPIC within muscle proprioceptors is unknown, but previous
studies have shown the 5-HTP increases the output from muscle spindles that have
been de-efferented by ventral root section (Ellaway and Trott, 1975). This suggests that
serotonin through an unknown receptor can modulate muscle spindle output
peripherally. Future studies are needed to identify and characterize modulation of
NaPIC in muscle proprioceptors.
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Conclusion

Results with riluzole in aim one establishes that impaired encoding intrinsic to
muscle proprioceptors following chronic OX likely results from disrupted NaPIC.
Application of 5-HT2 receptor agonists, quipazine and lorcaserin, which are known to
increase NaPIC, significantly restored muscle proprioceptor encoding following riluzole
and chronic OX respectively. Ventral root section determined that these 5-HT2 agonist
likely restored encoding by increasing gamma motoneuron output.
While the restoration of Ia muscle spindle encoding occurred indirectly by gamma
motoneuron activation, there is evidence to suggest that motoneuron function may also
be disrupted following chronic OX (Burakgazi et al., 2011; Tofthagen et al., 2012; Kneis
et al., 2015; Taleb et al., 2017). This suggests that disruption of NaPIC following chronic
OX may extend beyond muscle proprioceptors and may help account for fatigue and
weakness experienced by patients. Regardless of the exact mechanism, the
effectiveness of 5-HT2 agonists at restoring encoding suggest that they could
significantly improve behavioral deficits in animal and alleviate proprioceptive deficits in
patients.
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Fig. 10. 5-HT2 receptor agonist, quipazine significantly increase the duration of
static responsiveness following 6 mg/kg riluzole. (A,B) Representative traces of
action potential firing (gray lines) with instantaneous firing rates (black dots) in response
to muscle stretch (A,B bottom trace; 3mm 20 mm/s). (A) Acute injection of riluzole (6
mg/kg) reduced the duration of static responsiveness in Ia muscle spindle afferents. (B)
In the same animal, injection of quipazine (10 mg/kg) restored static responsiveness in
Ia muscle spindle afferents. (C) Mean ±SE for duration for static responsiveness in Ia
muscle spindle afferents in various treatment conditions.
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Fig. 11. Fig. 10. 5-HT2 receptor agonist, quipazine significantly decreased slow
dynamic threshold following riluzole 6 mg/kg. (A,B) Representative records of action
potential firing (gray lines) with instantaneous firing rates (black dots) in response to
ramp-hold-release muscle stretch (A,B bottom trace; 3mm 4 mm/s, 1 s hold phase). (A)
Injection of riluzole (6 mg/kg) increased the slow dynamic threshold (arrowheads) in Ia
muscle spindle afferents. (B) In the same animal, injection of quipazine (10 mg/kg)
reduced the slow dynamic threshold (arrowheads) in Ia muscle spindle afferents. (C)
Mean ± SE for duration for slow dynamic threshold in Ia muscle spindle afferents in
various treatment conditions.
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Fig. 12. 5-HT2C receptor agonist, lorcaserin significantly increase the duration of
static responsiveness following chronic OX. (A,B) Representative traces of action
potential firing (gray lines) with instantaneous firing rates (black dots) in response to
muscle stretch (A,B bottom trace; 3mm 20 mm/s). (A) Chronic OX reduced the duration
of static responsiveness in Ia muscle spindle afferents. (B) In the same animal, injection
of lorcaserin (2 mg/kg) restored static responsiveness in Ia muscle spindle afferents. (C)
Mean ±SE for duration for static responsiveness in Ia muscle spindle afferents in various
treatment conditions.
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Fig. 13. 5-HT2C receptor agonist, lorcaserin significantly decreased slow dynamic
threshold following chronic OX. (A,B) Representative records of action potential firing
(gray lines) with instantaneous firing rates (black dots) in response to ramp-hold-release
muscle stretch (A,B bottom trace; 3mm 4 mm/s, 1 s hold phase). (A) Chronic OX
increased the slow dynamic threshold (arrowheads) in Ia muscle spindle afferents. (B)
In the same animal, injection of lorcaserin (2 mg/kg) reduced the slow dynamic threshold
(arrowheads) in Ia muscle spindle afferents. (C) Mean ±SE for duration for slow
dynamic threshold in Ia muscle spindle afferents in various treatment conditions.
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Fig. 14. Ventral root section eliminated the effects of quipazine or lorcaserin on
static responsiveness (A, B) and slow dynamic threshold (C,D). (A-D) Mean ±SE
for duration for static responsiveness and slow dynamic threshold in Ia muscle spindle
afferents following quipazine (A,C) or lorcaserin (B,D) before and after ventral section.
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Chapter VI
Specific Aim 3: To determine if spontaneous activity following acute OX in
muscle proprioceptors arises from sensory nerve terminals

Introduction

Neurotoxic side effects of the highly effective chemotherapy agent, oxaliplatin
(OX) limit its clinical efficacy. OX is commonly used as an adjuvant to surgical tumor
removal, and significantly improves five-year survival rates (Andre et al., 2009). However
during and following cessation of treatment patients are burdened with debilitating
neurotoxicity, which significantly diminishes quality of life. Within hours and for days
following OX infusion, greater than 90% of patients experience abnormal sensations
(paresthesia), pain (dysesthesia), muscle spasm and fasciculation, and cold induced
allodynia. (Argyriou et al., 2008; Argyriou et al., 2014). These positive symptoms
typically last less than one week, but re-occur and often worsen following every infusion
(Park et al., 2013). The common mechanism underlying these symptoms are changes
in the excitability of sensory and motor axons (Adelsberger et al., 2000; Wilson et al.,
2002; Lehky et al., 2004; Krishnan et al., 2005; Benoit et al., 2006; Krishnan et al., 2006;
Park et al., 2011b; Park et al., 2012a; Argyriou et al., 2013a). Conversely, accumulating
doses of OX result in chronic negative symptoms including numbness and tingling in the
toes and the feet, as well as sensory ataxia associated with poor balance and increased
risk for falls (Beijers et al., 2014; Briani et al., 2014; Cavaletti, 2014; Avan et al., 2015).
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These symptoms are thought to arise from a length dependent neuropathy (Beijers et
al., 2014; Briani et al., 2014; Cavaletti, 2014; Avan et al., 2015), however recent studies
have identified deficits in patients with no signs of neuropathy (Burakgazi et al., 2011).
Unlike the transient effects of acute OX, these symptoms persist with little improvement
years after drug cessation (Park et al., 2011a). It is unknown if there is a causal link
between the acute and chronic syndromes associated with OX chemotherapy, but
evidence shows a correlation between the severity of acute symptoms and the
development of chronic impairment (park 2009, Krishnan et al. 2006; Park et al. 2009b),
The positive symptoms following acute OX administration are commonly attributed
increased excitability in sensory and motor axons, caused by changes in voltage-gated
ion channels. For example, in vitro and in vivo studies of acute OX have shown changes
in voltage-gated Na+ channels, including hyperpolarized shifts in their activation and
inactivation (Adelsberger et al., 2000; Grolleau et al., 2001; Benoit et al., 2006). Studies
in patients have used threshold tracking techniques to suggest changes in voltage-gated
Na+ channels (Krishnan et al., 2006; Park et al., 2011b). The converging conclusion
from these studies is that OX is affecting the transient voltage gated Na+ channels
distributed throughout sensory and motor axons, resulting in the positive symptoms
experienced by patients.
Recent studies provide insight into the proposed link between acute and chronic
OX neurotoxicity. For example, genetic studies in patients have identified specific
polymorphisms in the voltage-gated Na+ channel gene correlated with the severity of the
acute and chronic syndrome (Argyriou et al., 2013b). Aim 1 of this dissertation identified
that OX disrupts specific voltage-gated Na+ channels in muscle proprioceptors leading to
impaired sensory encoding and behavior. That aim demonstrated that following a
clinically relevant dosage regime of OX muscle proprioceptors displayed impaired
sensory encoding; specifically they were unable to maintain repetitive firing. Further
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investigation of these changes showed that this encoding deficit resulted from disruption
of a subtype of voltage-gated Na+ current (persistent inward Na current) most likely
located in the sensory nerve terminal. NaV 1.6, which is known to mediate a NaPIC
localizes to the sensory terminal in muscle proprioceptors (Carrasco et al., 2017). This
finding suggests that in addition to the dorsal root ganglion, OX may cause changes in
the distal endings of sensory nerves. If acute hyper-excitability following OX is linked to
the chronic loss of excitability, then there may be changes within the sensory nerve
terminal following OX infusion.
The purpose of this study was to localize the changes following acute OX that
are responsible for the positive symptoms experienced by patients. We applied in vivo
electrophysiological techniques to localize changes in excitability following acute OX
administration. Our in vivo rat model shows all of the signs of acute OX neurotoxicity
including spontaneous activity in sensory axons, and muscle fasciculation with
corresponding repetitive EMG bursting similar to that observed in patients. Following
acute OX injection we tested the excitability of individual sensory axons and applied
novel spike triggered averaging techniques to localize the origin of spontaneous firing in
sensory axons and EMG bursting.

Methods

Acute OX Studies
These studies were designed to test effects of acute OX treatment on sensory
and motoneurons. Oxaliplatin, (BIOTANG, Lexington, MA) dissolved in 5% dextrose was
administered via intraperitoneal (IP) injection one day prior to terminal experiments. Two
different dosages were used in this study 20, or 30 mg/kg. The higher dose increased
the proportion of spontaneous activity available for STA analysis. Spontaneous sensory
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and motor activity was observed, and STA analysis produced the same result at the 20
mg/kg dose.

Recording Preparation/ Data Collection
In order to sample muscle proprioceptors, dorsal roots were isolated and placed
on bipolar recording hook electrodes. Rootlets were tested for orthodromic action
potential volley, and stretch sensitive activity. Within dorsal rootlets individual sensory
axons were penetrated with sharp glass microelectrodes filled with 2M K+ Acetate-.
Sensory axons were randomly sampled and selected for recording when they displayed
orthodromic action potentials with a conduction delay of < 3 ms following peripheral
electrical stimulation of triceps surae nerves. During spike triggered averaging
experiments ventral roots were placed in continuity with bipolar electrodes for recording
or stimulation to obtain the latency of the compound muscle action potential (CMAP).

Measurements of Axonal Excitability
As described above, individual sensory axons were impaled and identified based
on orthodromic action potentials in response to stimulation of the Mg/LgS nerves.
Techniques described below are the same as those previously used to measure axon
parameters (Novak et al. 2009). For the purposes of this study excitability measures
were only assess from group Ia and Ib muscle proprioceptors. When membrane
potential was -40 mV or less and action potential amplitude was ≥ 40 mV measurements
of axon properties were recorded. Depolarizing, 1 ms current pulses injected every
second at increments of 0.1 nA were used to determine rheobase current (the current
that triggered action potentials). Hyperpolarizing of the same duration and frequency at
1-3 nA was used to determine input resistance and to evoke action potentials at anode
break. Intra-axonal records of action potentials, membrane potential, current injection,
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and muscle length and force changes were digitized (20 kHz), and stored on a computer
for later analysis using Spike2 software.
Measurements of threshold for action potentials and amplitude were made by
manually placing cursors in Spike2 at point of inflection during the rising phase of the
action potential, and at its peak. The amplitude of the action potential was calculated as
the different between the membrane potential and the potential at the peak of the action
potential. In order to determine the maximal rate of rise during the action potential (max
DV/DT), the first derivative of the action potential was taken within Spike2. Lastly,
threshold was determined as the difference between the potential at which DV/DT was
equal to 100 and the resting membrane potential.

Spike Triggered Averaging
Spike triggered averaging techniques (STA) were used to assess the origin of
spontaneous firing from muscle proprioceptors following OX. These techniques have
been previously described for use in motoneurons, but the principles used here are
identical (Bullinger et al., 2011a). Intra-axonal records of spontaneous and mechanically
evoked action potentials from sensory axons was used to trigger an average from a
bipolar extracellular electrode located peripherally at the entry zone of the Mg/LgS. In
other instances, spontaneous EMG bursting was used to trigger an average from ventral
roots just distal to their entry into the spinal cord. Fig. 15 shows the general
experimental setup and placement of intracellular and extracellular recording electrodes.

Results

Intra-axonal recordings were obtained from 15 rats for analysis of axonal
excitability and STA techniques. Specifically, axonal excitability was studied in 4 control
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and 7 OX (20 mg/kg) rats 24 hours post injection. Five animals were used for sensory
STA analysis at doses of 20 (2 rats), and 30 mg/kg (3 rats) at 24 to 96 hours post
injection. Motor STA analysis was done in 5 animals 24 hours after injection of 30 mg/kg
OX.

Validation of the Rodent Model
Acute neurotoxicity following OX infusion is characterized by symptoms of
increased excitability in both sensory and motor systems. For days following infusion of
OX, patients describe both sensory and motor symptoms including: paresthesia, cold
induced pain, and muscle cramps/fasciculation (Argyriou et al., 2008; Park et al., 2009b;
Park et al., 2012a).
In our rodent model we observe sensory and motor dysfunction that persists for
days following acute OX injection. Fig. 16 shows examples of sensory dysfunction
following OX treatment. In Fig. 16A spontaneous activity recorded from a muscle
proprioceptor is shown, notice that firing continues despite shortening the muscle and
removing all force. Unprovoked firing in muscle proprioceptors is the proprioceptor
correlate of paresthesia arising from cutaneous afferents in patients (Argyriou et al.,
2013a). A correlate to cold induced symptoms is shown in Fig. 16B application of room
temperature mineral oil to the triceps surae muscles resulted in burst of activity recorded
intra-axonally from a Ia muscle spindle afferent. Lastly, Fig. 16C shows spontaneous
muscle activity similar to that observed in patients. Similar to the motor signs of hyperexcitability in patients, EMG showed repetitive (Fig. 16C, top trace) discharge with
corresponding force production (Fig. 16C, bottom trace). These electrophysiological
measures fit well with patient described muscle fasciculation and cramping following OX
infusion (Wilson et al., 2002; Lehky et al., 2004). Therefore our model of acute OX
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mimics the clinical presentation following OX infusion and suggest that findings in our
rodent model will be highly relevant to patients.

Additional Signs of Hyperexcitability
In addtion to the signs of hyperexcitability shown above, following OX treatment
bursting activity was observed in numerous cells. Similar to Fig. 16 above, Fig. 17A and
B show bursting activity in muscle proprioceptors without stimulation. In Fig. 17A the
brief burst of repetitive firing persist during muscle shortening (removal of stimulus). Fig.
17B shows a robust increase in repetitive firing for roughly 20 sec before returning to a
baseline despite no stimlutation (muscle stretch). Bursts of activity can also be induced
by muscle stretch. Fig. 17C and D show bursts of activity elicited by either ramp-holdrelease or trianguar muscle stretch that persist after after the muscle stretch paradigm is
removed. In fact, during these burst of activity the axons become unresponsive to
additional muscle stretch stimuli suggesting that their origin may be from the sensory
terminal responsible for generating action potentials.

Axonal Excitability
Hyperexcitability in muscle proprioceptors qualitatively mimics changes in
excitability that result in the positive symptoms in patients. The converging hypothesis
from other studies is that acute OX alters axonal voltage-gated Na+ channels. In order
to assess changes in Na+ channels we tested the excitability of individual sesnory axons
in vivo. Table 2 compares axonal parameters in control and acute OX animals.
Previous studies have demonstrated that OX shifts the activation and inactivation of
voltage-gated Na+ channels to more negative potentials. This shift would move
threshold closer to resting membrane potentials and would reduce the overall amplitude
of Na+ current. Fig. 18 looks at the relationship between resting membrane potential and
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the potential at which threshold is reached. As membrane potential becomes more
negative there is less build up of voltage-gated Na+ channel inactivation which results in
a lower threshold (Novak et al. 2009). Fig. 18B also shows that at a given membrane
potential cells recorded from OX animals may have slightly lower thresholds than
controls at a similar membrane potential.

If this were the case then the millivolts

needed to reach threshold should be reduced in OX cells. Fig. 18D shows the mean
millivolts to threshold is slighlty reduced in OX, but this did not reach significance.
Additionally, consistent with previous study we found that overall the amplitude of Na+
current was reduced in muscle proprioceptors following OX. Fig. 18A shows the effects
of resting membrane potential on the maximal rate of rise (max DV/DT). At similar
membrane potentials, axons following acute OX showed lower max DV/DT suggesting
that decreased number of voltage-gated Na+ channels were participating in the action
potential. Reduced max DV/DT also accounts for the reduction in action potential
amplitude in table 2. These changes may result from either decreased total numbers of
channels or by a hyperpolarized shift in the inactivation when compared to control
(Novak et al., 2009), which has been shown previously in acute OX (Adelsberger et al.,
2000; Grolleau et al., 2001; Benoit et al., 2006). A comparison of means shows that
while max DV/DT was reduced following OX, this effect did not reach significance.

Localizing the Acute Effects of OX
Our assessment of indivdiual axon excitability following acute OX showed similar
changes to those found in previous studies using in vitro or threshold tracking
techniques. While these changes are consistent with the previous literature, their
magnitude seemed insufficient to account for the robust spontaneous activity in muscle
proprioceptors. If changes in axon excitability seem insuffiicient to cause spontaneous
activity, then where does spontaneous activity originate?
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In order to answer this question we applied novel spike triggered averaging
(STA) techniques to localize the origin of spontaneous sensory and motor activity. If
spontaneous sensory and motor activity arise from a single epicenter, then we should
obtain a single average using STA. Conversly, if spontaneous activity arises from
numerous epicenters, as suggested by an increase in axonal exitability, then we should
either obtain multiple averages with different latencies, or no clear average at all.

Origin of Spontaneous Sensory Acivity
In 14 identified muscle proprioceptors from 7 rats spontaneous firing recorded
intra-axonally was used to trigger an average from the peripheral recording electrode. In
8 of these 14, stretch evoked activity was used to trigger and average from the
peripheral recording electrode. The latencies of spontaneously, and stretch evoked, and
electrically evoked (conduction delay) events were compared to determine the the origin
of spontaneous activity following acute OX. Fig. 19A and B shows two muscle
proprioceptors in which STA on spontaneous and stretch evoked activity was obtained.
In both cases spontaneously evoked STA latency occurs in the negative time window,
meaning that the spontaneous action potentials crossed the peripheral recording
electrode prior to being recorded intra-axonally in the dorsal roots. Comparison of these
latencies in each muscle proprioceptor with the latency of stretch evoked activity and the
electrically evoked delay confirms that spontaneous activity arose from a peripheral
origin, most likely the sensory nerve terminal. Fig. 20 compares the mean latencies for
spontaneously and stretch evoked STA, and the electrically evoked delay. Electrically
evoked delays were consistently the shortest, followed by spontaneous and then stretch
evoked. The slighlty longer latecny in stretch evoked may result from the relatively
higher firing rates achieved in response to stretching the muscle as compared to
spontaneous activity. Also, stretch evoked delays may have been effected by the act of
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stretching which moves the peripheral electrodes. Regardless, in no case was the
spontaneously evoked average faster than the electrically evoked delay for the same
muscle proprioceptor and there was no signifcant differences between groups.
STA analysis suggests that spontaneous activity in muscle proprioceptors is
arising from a peripheral epicenter, most likely the sensory nerve terminal. In order to
validate the STA method we applied the potent Na+ channel blocker bupivacaine locally
at the entry zone of the triceps surae nerves. If activity is arising from a peripheral
epicenter, than blocking action potential initation peripherally should eliminate activity
recorded from the dorsal roots. Fig. 21A and B shows two examples of the effects of
locally applied bupivacaine on spontaneous activity in a muscle proprioceptors. In both
cases spontaneous firing ceases within approximately 30 seconds. Conduction
blockade was confirmed in the second case (Fig. 21C) by failure to record action
potentials in response to muscle stretch. Results with bupivacaine confirm those
obtained by STA, that spontaneous activity in muscle proprioceptors arises from a
peripheral epicenter.

Origin of Spontaneous Motor Activity
In order to determine the origin of spontaneous muscle activity, we used
spontaneous EMG actitivty to trigger an average into ventral roots. If spontaneous
muscle activity results from abberrant motoneuron firing, then we should detect an
average in the negative time window at a latency consistent with the delay of the
compound muscle action potential. In 5 animals, spontaneous EMG activity was used to
obtain 8 averages from from ventral roots. Fig. 22 shows two of these examples with
their corresponding EMG and force traces. In Fig. 22A an average from that contained
two peaks with latencies of 3.2 and 3.5 ms. Fig. 21B shows another example of an
average containing two peaks with latencies of 2.9 and 3.3 ms respectively. The two
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different peaks in each of these examples likely arise from two different motor units with
slightly different conduction velocities.
The total range of STA latencies observed was from 2.02 to 4.1 ms, which is
consistent with the range of delays observed in the CMAP. All of these averages were
in the negative time window, meaning that the activity crossed the ventral root electrode
prior to being recorded by the EMG electrodes. Thus following acute OX spontaneous
motor activity arises from a spinal cord epicenter, most likely the motoneuron.
STA analysis demonstrates that spontaneous EMG activity results from motor unit firing
evident by the averages obtained within ventral roots. In order to validate the STA
technique we paired down the ventral root until discrimitable activity was evident. Fig.
23A shows the resulting ventral root record with clear activity (arrowheads). This activity
then traveled to the periphery and activates the muscle, resutling in the EMG trace
shown in Fig. 23B (3.8 ms delay). Activation of this motor unit causes a small increase
in muscle force showin in Fig. 23C.
If spontaneous muscle activity arises from motor unit firing, then blocking the
acetylcholine receptor with pancuronium bromide should block neuromusclar
transmission, eliminating spontaneous EMG activity. Fig. 24 shows the effect of
pancuronium bromide on spontaneous EMG activity. In the first instance all
spontaneous EMG activity ceases and there is no change in force (Fig. 24A). Paralysis
was confirmed by lack of force generation following supramaximal stimulation of the
triceps surae nerves (Fig. 24B). In a second animal pacuronium bromide was given and
paralysis was confirmed by lack of force production following nerve stimulation, however
spontaneous EMG activity was still present (Fig. 24C, top trace). Note that despite the
spontaneous EMG activity there is no increase in muscle force (Fig. 24C, bottom trace).
This result was observed in a third animal following pancuronium bromide and suggests
that in addtion to spontaneous motor unit activity originating in the spinal cord there is
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spontaneous activity intrinsic to the muscle fiber(s), similar to myotonia (Lehky et al.,
2004; Novak et al., 2009)

Disconnecting Sensory from Motor
The normal function of muscle proprioceptors is to provide feedback about
muscle length and force to the central nervous system. In the case of the Ia muscle
spindle afferent this occurs through a monosynaptic connection with alpha motoneurons.
Therefore, it is possible that spontaneous activity in muscle proprioceptors is contributing
to the spontaneous muscle activity observed with EMG. The converse is also true, that
spontaneous motor activity could be driving the firing from muscle proprioceptors. This
could occur either from the changes in muscle length and force associated with motor
unit firing, or in the case of muscle spindle direct input to intrafusal muscle fibers from
gamma motoneurons.
The only way to be sure that spontaneous activity in muscle proprioceptors is a
result of changes within the sensory cell it to eliminate the influence of alpha and gamma
motoneurons on extrafusal and intrafusal muscle fibers. This can be accomplished by
either i.p. injection of pancuronium bromide, a potent inhibitor of nicotinic acetylcholine
receptors, or by ventral root section. Fig. 25 shows the effects of both of these
procedures on spontaneous firing following OX. Clearly, spontaneous activity persists
after removal of motor influence by ventral root section (Fig. 25A) or pancuronium
bromide injection (Fig. 25B). In the same cell as Fig. 25B, STA analysis shows a latency
consistent with a peripheral epicenter (Fig. 25C). These results eliminate the possibility
that spontaneous motor activity is driving the spontaneous sensory activity.
Conversely, in order to eliminate any effect of spontaneous sensory inputs to
motoneurons we section the dorsal roots just prior to entering the spinal cord. Fig. 26
shows that even after eliminating sensory input, we still observed spontaneous EMG
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activity and increases in muscle force. Just as before, that activity triggered an average
in the ventral root in the negative time window. Thus, increased spontaneous activity
from muscle propricoeptors is not necessary for spontaneous motor unit discharge,
suggesting the OX is increasing the intrinsic excitability of motoneurons.

Discussion
Following clinically relevant doses of OX, our rodent model showed signs of
sensory and motor hyperexcitability which are qualitatively similar to the symptoms
experienced by patients. Our model showed spontaneous activity in muscle
proprioceptors which correlates with paresthesia experienced by patients. We also
observed spontaneous increases in muscle force with corresponding repetitive EMG
bursting. Further investigation showed that this activity resulted from motor unit
discharge and from myotonic like activity intrinsic to the muscle, both of which have been
observed in patients (Wilson et al., 2002; Lehky et al., 2004). Using novel in vivo intraaxonal recording techniques to assess the previoulsy reported increase in axonal
exctiability (Adelsberger et al., 2000; Grolleau et al., 2001; Benoit et al., 2006; Park et
al., 2011b) we found changes that seemed unlikely to account for the large amount of
spontaneous activity. We then used STA techniques to determine the origin of
spontaneous sensory and motor activity, and found that in both instances an epicenter
consistent with the normal sites of action potential initiation and not in axons or dorsal
root ganglion.

Origin of Spontaneous Sensory and Motor Activity
STA analysis demonstrates that spontaneous sensory and motor activity
following acute OX localizes to a single peripheral and central epicenter, respectively.
This must be the case for two reasons: 1. If a single average was obtained, then there is
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a single focal point generating activity, and 2. If the latency of these averages is
consistent with the normal electrically evoked delay then they must have originated at or
distal the recoding electode in the case of sensory activity and at or proxmimal to the
recording electrode in the case of motor activity. These two points eliminate the
possibility of multiple epicenters along the length of the motor and sensory neuron,
including the sensory neuron cell body in the dorsal root ganglion.
The origins of spontaneous sensory and motor activity were validated by further
experimental manipulation. Appilcation of bupivacaine to the nerve entry zone caused
conduction block and stopped spontaneous sensory acticity. This clearly demonstrated
the peripheral origin of spotaneous sensory activity. Spontaneous motor activity was
confirmed by fine dissection of ventral roots which allowed for single motor units to be
discriminated. This activity resulted in EMG activity with normal delay and force
production. Spontaneous motor unit activity was also confirmed by blocking
acetylcholine receptors with pancuronium bromide. Pancuronium bromide stopped
motor unit EMG bursting and revealed spontaneous EMG activity intrinsic to the muscle.
This activity likely results from the firing of random muscle fibers similar to myotonia
congentia (Novak et al., 2015). This finding is not surprising, as acute OX patients show
signs of myotonia like symptoms, such as percussion myotonia and EMG studies have
shown signs of myotonia (Wilson et al., 2002; Lehky et al., 2004). This myotonia like
activity was present in 2 out of 3 rats tested, however unlike the motor unit activity it
produced no detectable changes in force. This suggests that while there is likley an
increase in the intrinsic excitability of muscle fibers, the spontaneous firing in motor units
may have a larger role in the symptoms experienced by patients.
It is clear that both spontaneous sensory and motor activity origniate from sites of
normal action potential initiation. With respect to the motor side this is both the
motoneuron and individual muscle fibers. This demonstrates that in addition to a
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peripheral effect, OX has a significant effect within the central nervous system.
Localization of spontaneous activity to these sites provides insight into the underlying
mechanism(s).

Mechanism of Spontaneous Activity
The ability to generate trains of repetitive action potentials requires voltage-gated
Na+ channels. Votlage-gated Na+ channels conduct multiple types of Na current. For
instance, the transient Na+ current is responsible for the generation of action potentials,
and persistent inward Na currents (NaPICs) are essetial for generationg trains of action
potentials (Crill, 1996; Lee and Heckman, 1998, 2001; Harvey et al., 2006a). Transient
Na currents are necessarily present at action potential intiation sites, the distribution of
NaPIC is less obvious. However, given its essential role in repetitive firing, it or other
mechansism supporting reptititve firing must be present at every site that where trains of
action potentials are intitiated (Lee and Heckman, 2001). The role of voltage-gated Na+
channel dysfunction following acute OX has been studied in numerous species and
preparations, including human axons by threshold tracking. The prevailing conclusion
from these studies is that OX effects voltage-gated Na channels leading to an increase
in axonal excitability (Adelsberger et al., 2000; Grolleau et al., 2001; Benoit et al., 2006;
Krishnan et al., 2006; Park et al., 2011b).
In the motoneuron, NaPIC has been shown to be essential for the intiation and
maintenance of repetitive firing (Lee and Heckman, 1998, 2001; Harvey et al., 2006a).
Using pharmacologic blockade, NaPIC has also been show to be essential for muscle
proprioceptor encoding (Vincent et al., 2015). Study of Na+ currents in muscle have
identified a NaPIC that is present in individual muscle fibers (Gage et al., 1989).
Additionally, channels like NaV 1.6, which have been shown to carry a NaPIC (Rush et
al., 2007), in addition to a transient Na current, localize to the motoneuron axon initial
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segement (Kole and Stuart, 2012), sensory nerve terminal of muscle proprioceptors,
and cutaneous receptors (Lesniak et al., 2014; Carrasco et al., 2017). The majority of
stuides of acute OX neutoxicity have identified changes in the transient Na+ current.
Specifically, this is thought to occur by a shift in the activation and inactivation of the
voltage-gated Na+ current, which narrows the difference between resting membrane
potential and action potential threshold (Adelsberger et al., 2000; Benoit et al., 2006). In
a more recent study acute OX has been shown to increase NaPIC in sensory neurons
resulting in bursting (Sittl et al., 2012).
Insight into the relative contribution of transient Na+ current versus NaPIC to the
hyperexcitability following acute OX comes from the types of spontaneous activity. Both
sensory and motor spontaneous activity consists of bursts of repetitive firing. Fig.
17C&D shows bursts of activity set off by muscle stretch, suggesting that the
depolarization resulting from muscle stretch activated a current leading to a burst of
repetitive firing. Similarly, Fig. 16C shows a burst of repetitive EMG activity. As
discussed above, repetitive firing relies on NaPIC, suggesting that our findings may
result from changes in NaPIC.
Further support for a change in NaPIC comes from our assessment of axonal
excitability. While we observed changes similar to previous studies in transient Na+
current present in axons, the magnitude of these changes seem unlikely to be the main
contributor to the large amount of spontaneous activity in our model. Additionally, if
changes in transient Na+ current were the sole mechanism for spontaneous activity, then
we might have expected our STA results to be different. Transient Na+ current is
present at every node of ranvier along the sensory and motor axon. If changes in this
current would result in multiple epicenters that would either give no clear average with
STA analysis, or the localization of the epicenter would be at different points along the
axon. Our results with STA consistently localize to a single peripheral or central
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epicenter. Therefore, while changes in transient Na+ current cannot be ruled out as a
contributor to spontaneous activity, our results suggest that changes in NaPIC are the
major contributor. Said in another way, spontaneous activity is present without
significant changes in the transient Na+ current.
Based on previous studies and our results it is likely that acute OX causes an
increase in a NaPIC present at action potential initiation sites, where it increases
excitability resulting in spontaneous sensory and motor activity. With respect to
spontaneous motor unit discharge this increase likely occurs at the axon intitial segment.
Whereas dendrites, which also have NaPIC (Prather et al., 2001; Heckman et al., 2003;
Heckmann et al., 2005), may contribute to spontaneous activity initiated by synaptic
drive, our results demonstrate that dendritic NaPIC activated by synaptic input is not
necessary given that motor unit bursting persists after removing a large amount of
synaptic input by dorsal root section.
Spontaneous, myotonia like activity in muscle fibers likely arises from an
increase in the NaPIC normally found in skeletal muscle (Gage et al., 1989). Given that
muscle spindles are comprised of a sensory nerve terminal that innervates intrafusal
muscle fibers it is possible that some sensory activity could arise from spontaneous
discharge and contraction of the intrafusal fibers they innervate. While this could
contribute, the majority of activity likely arises from increased NaPIC that is present and
essential for normal encoding in the sensory nerve terminal.

Conclusion
OX infusion results in debilitating sensory and motor symptoms. We have
demonstrated that our rodent muscle proprioceptor model shows qualitatively similar
types of spontaneous activity in sensory and motor systems. Following acute OX, we
observed spontanteous activity in muscle proprioceptors, EMG bursting, and
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temperature dependent increases in activity. Previous studies have suggested that
these symptoms arise from changes in votlage-gated Na+ channels present in sensory
and motor axons (Adelsberger et al., 2000; Grolleau et al., 2001; Wilson et al., 2002;
Benoit et al., 2006). We tested this hypothesis by assessing the excitabilty of individual
axons using in vivo intra-axonal recordings. The changes, while similar to previous
studies were very small and seemed unlikely to account for the amount of spontaneous
activity we observed. Further analysis using novel STA techniques localized the origin
of spotaneous sensory and motor activity to the normal site of action potential initiation,
ie sensory nerve terminal, motoneuron, and muscle fiber. This suggests that OX targets
specific mechanisms at these locations. Given that spontaneous activity consisted of
bursts of repetitive firing our results suggest that acute OX may increase NaPIC present
at action potential initiation sites. This finding fits well with results from aim 1, which
suggests that chronic OX effects NaPIC present at the sensory nerve terminal. Overall
our report provides insight into the effects of acute OX and suggest that changes in
NaPIC may link acute and chronic changes following OX.
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Fig. 15 Experimental Setup. Evoked and spontaneous action potentials were recorded
intra-axonally within dorsal roots. These action potentials were used to trigger an
average from the peripheral bipolar electrode. The latencies of electrically, stretch
evoked and spontaneous averages will be compared. Spontaneous EMG spikes
recorded from the triceps surae were used to trigger averages from ventral roots. The
latency of these averages were compared with the compound muscle action potential
latency elicited by ventral root stimulation.
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Fig. 16. Validation of acute OX neurotoxicity in our rodent model. Representative
traces, A,B gray lines are action potentials, black dots show instaneous firing rates. (A)
Spontaneous activity from a muscle proprioceptor following OX injection. Note that the
muscle proprioceptor keeps firing despite decreasing muscle length and force. (B)
Burst of activity from a muscle proprioceptor following application of room temperature
mineral oil to the body of the triceps surae muscle. Force trace below shows the
moment when oil was applied. (C) EMG trace (top) showing repetitive motor unit
discharge and corresponding force production (bottom trace).
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Fig. 17. Representative examples of bursting activity following OX. Representative
traces of spontaneous activity (A-D), gray lines are action potentials, black dots show
instaneous firing rates. (A) Brief bursts of activity from a muscle proprioceptor that
persist despite muscle shortening. (B) Extended period of unprovoked repetitive firing.
(C,D) Bursting activity in muscle proprioceptors can be initated by muscle stretch (C)
ramp hold release, 3 mm, 4 mm/s, 1 sec hold phase, (D) triangular stretch, 3 mm 4
mm/s).
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Fig. 18. Measures of axonal excitability in control and OX treated rats. (A) Plot of
max DV/DT (rate of rise of the action potential) versus membrane potential. Compared
to control, OX axons have lower max DV/DT suggesting lower less Na+ channels are
participating in action potential formation. (B) Changes in threshold are largely
attributed to changes in membrane potential. There is some tendency for OX axons to
fall below the line, suggesting that they rest closer to threshold. (C) Mean ± SE
comparison of max DV/DT in control and OX axons. (D) Mean ± SE comparison of
millivolts to threshold in control and OX axons.
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Table 2. Assessment of excitability parameters in axons. In control (4 rats) and 24
hours after acute oxaliplatin (20 mg/kg, 7 rats) axonal parameters were recorded intraaxonally in terminal experiments. n, number of afferents pooled within groups. Nested
ANOVA and Tukey’s post hoc tests were used to test for the significance of group
differences. * P < 0.05
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Fig. 19. Two representative examples of spike triggerd averaging in muscle
proprioceptors showing spontaneous activity. Dashed line denotes time zero (time
of action potential recorded intra-axonally). (A,B) Averages obtained using STA from
stretch (top) and spontaneous (bottom) activity in muscle propricoeptors following OX.
(C) Mean ± 95% confidence interval comparison of latencies from spontaneous, stretch
evoked averages with the electrically evoked delay.
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Fig. 20. Comparison of electrically evoked delay with STA latencies from
spontaneous and stretch evoked activity. Mean ± 95% confidence interval
comparison of latencies from spontaneous, stretch evoked averages with the electrically
evoked delay.

114

115

Fig. 21. Effects of bupivacaine applied locally to the nerve entry zone. A-C gray
lines are action potentials, black dots show instaneous firing rates.

(A,B) Arrowheads

show when bupivacaine was locally applied. Within 30 sec spontaneous activity ceased.
(C) Conduction block was confirmed in the cell shown in B, by an absence of stretch
responses.
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Fig. 22. STA analysis of spontaneous EMG activity. Dashed lines denote time zero
(time at which the EMG spike occurred). (A,B) Two examples of averages (bottom
trace) in ventral roots obtained from spontaneous EMG activity (top trace) with
corresponding changes in force (middle trace).
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Fig. 23. Spontaneous motor unit firing results in EMG activity and corresponding
increase in muscle force. (A) Ventral root record from bipolary recording elcetrode
shows two bursts of activity (arrowheads). (B) EMG record with activity arising 3.8 ms
after ventral root activity. (C) Muscle force trace showing increases in muscle for
following EMG activity.
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Fig. 24. Spontanous muscle activity results from motor unit and muscle fiber
firing. (A) EMG record (top trace) showing spontaneous activity with corresponding
changes in force (bottom trace). Following injection of pancuronium bromide EMG
activity disappears. (B) Following pancuronium bromide injection supramaximal
simtulation of the periphaeral nerve (arrowheads) results in no increase in muscel force.
(C) Following paralyzation with pancuronium bromide, EMG record (top trace) showing
spontaneous muscle fiber activity with no change in muscle force (bottom trace).
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Fig. 25. Elimination of motor influence had no effect on spontaneous activity in
muscle proprioceptors. (A) Ventral root section prior to recording did not prevent
spontaneous firing. (B) Similarly, paralyzation with pancuronium bromide had no effect
on spontaeous activity. (C) In the same cell as (C), pancuronium injection had no effect
on the STA latency.
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Fig. 26. Elimination of sensory input had no effect on spontaneous muscle
activity. Cutting dorsal roots did not eliminate spontaneous EMG bursting (top trace) or
force production (middle trace). STA analysis of EMG record produced an average
(bottom trace) from ventral roots.
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Chapter VII

Conclusions
Adjuvant treatment with OX chemotherapy results in neutotoxic side effects
which greatly impact the lives of patients during and long after cessation of treatment.
Given the realtively high diease free survival rate following colorectal cancer, these
neurotoxic sides effects force patients to endure a lower quality of life. Aims in this
disseration specifically target acute and chronic OX neurotoxicity. We have identified
novel mechanisms of proprioceptive deficits following chronic OX that may account for
the disparity in the severity of patient reported symptoms and those predicted by
physicians. Our study of acute OX has led to novel conclusions about where activity that
underlies symptoms originates and how this might shed light on the underlying
mechanisms.

Chronic OX Neurotoxicity
Our animal model of chronic OX replicates the clinical scenario in which patients
without neuropathy develop debilitating proprioceptive deficits. Through our use of in
vivo electrophysiology we identified a deficit in encoding which correlated with the
severity of behavioral impairement. Through pharmacologic investigation we discovered
that OX most likley disrupted a NaPIC necessary for normal propricoeptor function. This
finding is novel and provides for the first time an explanation of deficits without
neuropathy. Importantly this finding may also help explain the disparity in severity of
symptoms described above and provides a potential therapeutic target (Fig. 27).
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Targeting NaPIC was capable of restoring encoding, and because of the correlation
between the encoding deficit and behavioral impairment, suggests that this treatment
may alleviate proprioceptive deficits following chronic OX.

Acute Neurotoxicity
Our acute OX model shows qualitatively similar changes to those that underlie
positive symptoms in patients. It is evident from our results and previous studies that
these symptoms arise from an increase in excitability. Unlike previous studies,
significant changes in axonal excitability as assesed by measurements of transient Na+
current were not present. Further investigation with STA techniques localizes these
changes to the normal action potential initiation sites. This and the types of activity
present suggested that acute OX may be altering excitability, potentially by increasing
NaPIC.

Connecting Acute and Chronic OX Neurotoxicity
A major goal of OX research has been to identify a causal link between acute
and chronic forms of OX neurotoxicity. Previous studies have identified that the
development and severity of acute symptoms correlates with the development and
severity of chronic symptoms (Krishnan et al., 2006; Park et al., 2009a). Specific
polymoprhisms in voltage-gated Na+ channels have been shown to correlate with the
severity of acute and chronic OX neurotoxicity (Argyriou et al., 2013b). The studies have
provided support for a link between acute and chronic OX neurotoxicity, but have failed
to identify a causal link or to develop a perventative treatment.
This results presented above provide for the first time, insight into a potential
unified mechanism for acute and chronic OX neurotoxicity. Results in this dissertation
demonstrate two main points: 1. Acute and chronic OX neurotoxicity localize to the
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sensory nerve terminal, and 2. Acute and chronic OX neurotoxicty may have opposite
effects on NaPIC. Acute OX likely increases NaPIC in muscle proprioceptors leading to
spontaneous activity for days following injection. After several injections of OX and after
treatment cessartion, NaPIC is decreased in muscle proprioceptors leading to impaired
encoding.
These results suggest that NaPIC activity is being homeostatically controlled.
Regulation of NaPIC based on cellular excitability has been shown in other clinical
scenarios. For instance, following chronic spinal cord injury, in order to compensate for
loss of descending excitatory inputs and lower motoneuron excitability, there is a
clinically significant increase in PICs within motoneurons leading to spasticity (Gorassini
et al., 2004; Li et al., 2004; Murray et al., 2010; Murray et al., 2011).
We propose that during OX treament the increased excitability and positive
symptoms experienced by patients result from increased NaPIC in sensory and
motoneurons. After mulitple infusions of OX, hyperexcitability stresses sensory and
motoneurons. In an attempt to compensate the neurons reduce their excitability by
decreasing the amount of NaPIC, contributing to the negative symptoms experienced by
patients. Although not studied here, a failure to reduce exctiability may result in
excitotoxicity and cell death consistent with the other proposed cause of chronic OX
neurotoxicity (Carozzi et al., 2015). Acute hyperexcitability is a potential therapeutic
target aimed at alleviating the positive symptoms experienced by patients and
preventing the development of chronic persistent negative symptoms (Fig. 27).
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Fig. 27. Clinical progression of OX neurotoxicity. In the majority of patients acute
neurotoxicity occurs with every OX infusion. Accumulating doses of OX result in chronic
neurotoxicity, which persists after treatment cessation. Aim 2 established a potential
therapeutic target to alleviate chronic neurotoxic symptoms. If acute and chronic
neurotoxicity are casually linked, then blocking acute changes will prevent the
development of chronic symptoms.
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Appendix A: Commonly used Abbreviations

OX

Oxaliplatin

CIPN

Chemotherapy induced peripheral neuropathy

PIC

Persistent inward current

NaPIC

Sodium persistent inward current

SNAP

Sensory nerve action potential

STA

Spike triggered averaging

EMG

Electromyograph

I.P.

Intraperitoneal

Mg/LgS

Medial gastrocnemius/Lateral gastrocnemius and Soleus muscles

DV/DT

Rate of rise of action potential

DEG/ENaC

Mechanically gated Na+ channel

Peizo 2

Mechanically gated ion channel

CI

Confidence Interval

nA

Nanoamps

ms

Millisecond

mg/kg

Milligrams/kilogram

NaV

Voltage-gated Na+ channel

PCO2

Partial pressure expired carbon dioxide

µm

Micrometers

Ril

Riluzole
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OX

Oxaliplatin

Ia

primary muscle spindle afferent

Group II

Secondary muscle spindle afferent

Ib

Primary golgi tendon organ afferent
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